<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?DTDIdentifier.IdentifierValue http://null/schema/dtds/document/fulltext/xcr/xocs-article.xsd?><?DTDIdentifier.IdentifierType schema?><?SourceDTD.DTDName xocs-article.xsd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName ftrr2jats.xsl?><?ConverterInfo.Version 1?><?origin publisher?><?OLF?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Ayurveda Integr Med</journal-id><journal-id journal-id-type="iso-abbrev">J Ayurveda Integr Med</journal-id><journal-title-group><journal-title>Journal of Ayurveda and Integrative Medicine</journal-title></journal-title-group><issn pub-type="ppub">0975-9476</issn><issn pub-type="epub">0976-2809</issn><publisher><publisher-name>The Authors. Published by Elsevier B.V. on behalf of Institute of Transdisciplinary Health Sciences and Technology and World Ayurveda Foundation.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7430223</article-id><article-id pub-id-type="publisher-id">S0975-9476(20)30066-8</article-id><article-id pub-id-type="doi">10.1016/j.jaim.2020.08.003</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Immunity against COVID-19: Potential role of <italic>Ayush Kwath</italic></article-title></title-group><contrib-group><contrib contrib-type="author" id="au1"><name><surname>Gautam</surname><given-names>Shankar</given-names></name><email>shankar.gautam@mohp.gov.np</email><xref rid="aff1" ref-type="aff">a</xref><xref rid="cor1" ref-type="corresp">&#x02217;</xref></contrib><contrib contrib-type="author" id="au2"><name><surname>Gautam</surname><given-names>Arun</given-names></name><xref rid="aff2" ref-type="aff">b</xref></contrib><contrib contrib-type="author" id="au3"><name><surname>Chhetri</surname><given-names>Sahanshila</given-names></name><xref rid="aff3" ref-type="aff">c</xref></contrib><contrib contrib-type="author" id="au4"><name><surname>Bhattarai</surname><given-names>Urza</given-names></name><xref rid="aff4" ref-type="aff">d</xref></contrib><aff id="aff1"><label>a</label>Ministry of Health and Population, Kathmandu, Nepal</aff><aff id="aff2"><label>b</label>Ministry of Social Development, Gandaki Province, Nepal</aff><aff id="aff3"><label>c</label>TU Ayurveda Teaching Hospital, Kirtipur, Nepal</aff><aff id="aff4"><label>d</label>MCOMS, Pokhara, Nepal</aff></contrib-group><author-notes><corresp id="cor1"><label>&#x02217;</label>Corresponding author. <email>shankar.gautam@mohp.gov.np</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>17</day><month>8</month><year>2020</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="epub"><day>17</day><month>8</month><year>2020</year></pub-date><history><date date-type="received"><day>14</day><month>5</month><year>2020</year></date><date date-type="rev-recd"><day>22</day><month>7</month><year>2020</year></date><date date-type="accepted"><day>10</day><month>8</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 The Authors</copyright-statement><copyright-year>2020</copyright-year><license><license-p>Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</license-p></license></permissions><abstract id="abs0010"><p>SARS-CoV-2 infection associated respiratory disease- COVID-19 has evolved into a pandemic but, being a new form of virus, pathogenesis of disease causation is not fully understood and drugs and vaccines against this virus are still being tested so that no effective drugs or vaccines have been advised by regulatory authority. In this context, the Ministry of AYUSH, Government of India has recommended &#x02018;<italic>Ayush Kwath</italic>&#x02019; to improve the immunity and combat the infection. Our objective of this literature review is to review the role of immunity in pathogenesis of COVID-19 and role of <italic>Ayush Kwath</italic> against the virus and regulation of immunity. Current review was conducted using a search of available literature on COVID-19 and immunity, <italic>Vyadhikshamatwa</italic>, Ayurveda and COVID-19, <italic>Rasayana</italic>, Coronavirus, SARS-CoV-2, immunomodulatory effects of medicinal plants; <italic>Tulsi</italic>/Holy Basil/<italic>Ocimum sanctum</italic>, <italic>Dalchini</italic>/Cinnamon/<italic>Cinnamomum zeylanicum</italic>, <italic>Sunthi</italic>/Ginger/<italic>Zingiber officinale</italic> and <italic>Marich</italic>/Black Pepper/<italic>Piper nigrum</italic>. Ayurveda, being an ancient science have both medicinal and cultural values and had stimulated our kitchen and influenced what we ate in different seasons and the remedies we used for common ailments. Herbs such as <italic>Tulsi, Marich, Sunthi, Dalchini</italic> are the most commonly used and easily available drugs in home. Thus, <italic>Ayush Kwath</italic> due to its immune-modulatory, antiviral, anti-oxidant, anti-inflammatory, anti-platelet, anti-atherosclerotic, hepato-protective, reno-protective properties; seems to be effective in immuno-regulation for controlling viral infections like COVID-19. Further pre-clinical and clinical trials need to be done for the evaluation of safety and efficacy of this polyherbal formulation.</p></abstract><kwd-group id="kwrds0010"><title>Keywords</title><kwd>Ayurveda</kwd><kwd>COVID-19</kwd><kwd>SARS-CoV-2</kwd><kwd>Coronavirus</kwd><kwd>Immunity</kwd><kwd>Ayush</kwd></kwd-group></article-meta></front><body><sec id="sec1"><label>1</label><title>Introduction</title><p id="p0010">COVID-19, also known as severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) is an infectious disease believed to be originated from bats and transmitted to human beings [<xref rid="bib1" ref-type="bibr">1</xref>]. Being a new form of virus, pathogenesis of disease causation is not fully understood and drugs and vaccines against this virus are still being tested so that no effective drugs or vaccines have been advised by regulatory authority. Not only for Coronavirus, have many other viruses also lack preventive vaccines and effective antiviral medications. Studies have explored that these viruses can form drug-resistant mutants, which decrease the existing drug&#x02019;s efficacy. So, these viruses can be a threat to the mankind for long time [<xref rid="bib2" ref-type="bibr">2</xref>].</p><p id="p0015">High mortality among immune-compromised and those with some underlying pathology implies that the factors that improve immunity can prevent serious manifestations due to COVID-19 infection [<xref rid="bib3" ref-type="bibr">3</xref>]. Many herbal products are found to have immune-modulatory and antiviral property, so their discovery can be a milestone in the prevention and control of COVID-19 [<xref rid="bib2" ref-type="bibr">2</xref>]. In this context, the Government of India has recommended to take &#x02018;<italic>Ayush Kwath</italic>&#x02019; in order to boost the immunity. As this is a new formulation, this needs to be validated scientifically. We have made an attempt to review the immune-pathogenesis of COVID-19 and the role of each herb over it.</p></sec><sec id="sec2"><label>2</label><title>Immunopathogenesis of COVID-19</title><p id="p0020">The &#x02018;S&#x02019; protein of coronavirus can bind to host cells through the ACE2 receptor found in the oral and nasal mucosa [<xref rid="bib1" ref-type="bibr">1</xref>,<xref rid="bib4" ref-type="bibr">4</xref>]. Other sites where ACE2 receptors are found are lungs, stomach, intestine, bladder, heart, and kidney [<xref rid="bib5" ref-type="bibr">5</xref>]. Variable presentation of disease in different age groups, serious manifestations that are seen more commonly in immune-compromised, old aged and in those with underlying pathology, many asymptomatic cases in pediatric age group, and presence of lymphopenia in the majority of the cases; these factors implies that immunity has a vital role in the pathogenesis of COVID-19 [<xref rid="bib1" ref-type="bibr">1</xref>,<xref rid="bib6" ref-type="bibr">[6]</xref>, <xref rid="bib7" ref-type="bibr">[7]</xref>, <xref rid="bib8" ref-type="bibr">[8]</xref>]. It is assumed that our immune system has lack of memory against such a virus that gave it an edge over humans [<xref rid="bib3" ref-type="bibr">3</xref>].</p><p id="p0025">Viruses cause cell destruction mainly in two ways; direct cytopathic effects of the virus and immune response mediated destruction [<xref rid="bib9" ref-type="bibr">9</xref>]. COVID-19 cannot lyse the cells directly as the major pathway of cell destruction is due to immune-mediated destruction [<xref rid="bib10" ref-type="bibr">10</xref>,<xref rid="bib11" ref-type="bibr">11</xref>]. It has been mentioned that unlike adults, less vigorous cell-mediated immune response in alveoli of children results in being asymptomatic in the majority of cases [<xref rid="bib3" ref-type="bibr">3</xref>].</p><p id="p0030">The pathogenesis can be split into two stages: Non-severe and Severe [<xref rid="bib12" ref-type="bibr">12</xref>].</p><sec id="sec2.1"><label>2.1</label><title>Non-severe stage</title><p id="p0035">The virus fuses with the host cell membrane and enters inside the host cell through airway epithelium [<xref rid="bib13" ref-type="bibr">13</xref>,<xref rid="bib14" ref-type="bibr">14</xref>]. The virus propagates and multiplies inside the host cell and can reach lower airway and alveoli. In adults with good innate cellular and humoral immunity propagation of virus can be limited and viral load reaching alveoli can be reduced thus recovery can take place within 2&#x02013;3 weeks with mild symptoms [<xref rid="bib3" ref-type="bibr">3</xref>].</p><p id="p0040">Humoral immunity prevents the viruses to enter new cells while cell-mediated immunity targets on eradicating virus-infected cells [<xref rid="bib1" ref-type="bibr">1</xref>,<xref rid="bib15" ref-type="bibr">15</xref>]. In this stage, a strong immune system can be helpful in preventing the propagation of the virus thus reducing the severity of the disease [<xref rid="bib12" ref-type="bibr">12</xref>].</p></sec><sec id="sec2.2"><label>2.2</label><title>Severe stage</title><p id="p0045">Once the immune system is breached, the virus propagates and reaches the lower respiratory tract and alveoli. Then the virus can penetrate alveoli and reaches systemic circulation causing viremia [<xref rid="bib3" ref-type="bibr">3</xref>]. The virus binds to multiple organs having ACE2 receptor protein. During this stage, cell-mediated immunity becomes robust and starts releasing various pro-inflammatory cytokines (IFN-&#x003b1;, IFN-&#x003b3;, IL-1B, IL-6, IL-12, IL-18, IL-33, TNF-&#x003b1;, etc.) and chemokines (CCL2, CCL3, CCL5, CXCL8, CXCL9, CXCL10, etc.) causing damage to multiple organs known as Cytokine storm [<xref rid="bib16" ref-type="bibr">16</xref>,<xref rid="bib17" ref-type="bibr">17</xref>]. We may need to suppress the inflammation for improvement during this severe stage [<xref rid="bib12" ref-type="bibr">12</xref>]. IL-6 receptor antagonist (Tocilizumab), and anti-inflammatory interleukin (IL-10) are proposed to have a therapeutic role in the reduction of severity and mortality of COVID-19 [<xref rid="bib18" ref-type="bibr">18</xref>,<xref rid="bib19" ref-type="bibr">19</xref>]. As increased risk of thromboembolic phenomena is also found to be associated with COVID-19, prophylactic antithrombotic medications are advised during this stage [<xref rid="bib20" ref-type="bibr">20</xref>].</p></sec></sec><sec id="sec3"><label>3</label><title>Ayurveda purview</title><sec id="sec3.1"><label>3.1</label><title>Disease concept</title><p id="p0050">It seems that most early cases had a history of contact with the original market for seafood, but the disease has now advanced to be transmitted through human to human contact [<xref rid="bib1" ref-type="bibr">1</xref>]. Thus, this disease can be considered as Communicable-both contagious and infectious diseases. In Ayurveda, epidemics are discussed under the term of <italic>Janapadodhwamsa</italic> [<xref rid="bib21" ref-type="bibr">21</xref>, C.S.Vi. 3/5-6] by Charaka and <italic>Maraka</italic> by Sushruta [<xref rid="bib22" ref-type="bibr">22</xref>, S.S.Soo. 6/17]. The symptoms like fever, cough, breathing difficulty, headache, and vomiting resemble with clinical features of SARS [<xref rid="bib22" ref-type="bibr">22</xref>, S.S.Soo. 6/19]. Dalhana in his commentary has mentioned that symptoms like anosmia, cough, catarrh will occur after the entry of contaminated air through the nasal opening which is similar to typical clinical features of COVID-19 [<xref rid="bib22" ref-type="bibr">22</xref>, S.S.Soo. 6/19]. Furthermore, this disease can be classified as <italic>Adidaivika Bala Pravritta Vyadhi</italic> (ABPV), <italic>Sansargaja</italic>, <italic>Upsargaja</italic>, and <italic>Aupasargic Roga</italic>. ABPV are those diseases arising due to causes that cannot be controlled by human intelligence. <italic>Upasargaja Vyadhi</italic> are those fever-like diseases that manifest due to close contact with diseased persons [<xref rid="bib22" ref-type="bibr">22</xref>, S.S.Soo. 24/7] whereas <italic>Sansargaja Vyadhi</italic> resides with people who are cursed by almighty god i.e. due to influence of invisible forces/forces behind human control [<xref rid="bib22" ref-type="bibr">22</xref>, S.S.Soo. 24/7]. <italic>Aupasargic Vyadhi</italic> is defined in two different ways by Sushruta; one as a disease which spreads from one person to another person [<xref rid="bib22" ref-type="bibr">22</xref>, S.S.Ni. 5/33-34] and another as &#x02018;&#x02026;<italic>Upadravasangyah</italic>&#x02019; i.e. complications or associated diseases that manifest after primary disease [<xref rid="bib22" ref-type="bibr">22</xref>, S.S.Soo. 35/18]. Susruta mentions the diseases like <italic>Jwara, Kustha</italic> (skin diseases), <italic>Shosha</italic> (tuberculosis), <italic>Netrabhisyandi</italic> (conjunctivitis), and other <italic>Aupasargika roga</italic> (alike communicable diseases) can be spread through <italic>Prasanga</italic> (intimate relationship), <italic>Gatra Sansparsha</italic> (direct contact), <italic>Nishwasa</italic> (breathing or airborne), <italic>Sahabhojana</italic> (eating together), <italic>Sahashayana</italic> (sleeping together), sharing and using of others&#x02019; clothes, ornaments, ointments, etc. [<xref rid="bib22" ref-type="bibr">22</xref>, S.S.Ni. 5/33-34].</p><p id="p0055">
<italic>Agantuja Vyadhi</italic> (&#x0007e; diseases of exogenous origin) occurs due to physical/external factors like <italic>Bhuta, Visha, Vayu, Agni,</italic> and <italic>Prahara</italic> (trauma), etc. without any involvement of <italic>Vataadi Dosha</italic> initially; however, in later stage dosha are involved in the disease process [<xref rid="bib21" ref-type="bibr">21</xref>, C.S.Soo11/45]. Cakrapa&#x01e47;idatta clarifies that <italic>Bhuta</italic> means <italic>Visak&#x01e5b;imi</italic> or a virulent organism [<xref rid="bib21" ref-type="bibr">21</xref>, C.S.Sa.1/121]; <italic>Krimi</italic> may be <italic>Sahaja</italic> (natural) or <italic>Vaikarika</italic> (pathogenic) organisms that may be visible (macroscopic) or invisible to the naked eye (microscopic) [<xref rid="bib21" ref-type="bibr">21</xref>, C.S.Vi. 7/9,11].</p><p id="p0060">Thus, it is difficult to correlate this disease with specific Ayurveda terminology but, while interpreting the disease on the basis of <italic>Samprapti</italic> by considering the causative agent and the clinical features like fever (<italic>Jwara</italic>), cough (<italic>Kasa</italic>), anorexia (<italic>Aruchi</italic>), fatigue (<italic>Tandra</italic>), generalized body ache or myalgia (<italic>Angamarda</italic>) and Tiredness; it can be contemplated as an <italic>Agantuka Vyadhi</italic> which later on due to the involvement of dosha develops to <italic>Nija Vyadhi</italic> as <italic>Kapha-Vatolvana Hina Pitta Sannipataja Jwara</italic> (Severe <italic>Vata</italic> and <italic>Kapha</italic> with mild <italic>Pitta</italic>) [<xref rid="bib21" ref-type="bibr">21</xref>, C.S.Soo. 11/45; C.S.Chi. 3/92]. While talking about the pathogenesis of fever in Ayurveda, Charaka mentioned that when <italic>Vataadi</italic> dosha either singly or in <italic>Sansrista</italic> (two dosha) or in <italic>Sannipataja</italic> (all three dosha) got aggravated then it enters <italic>Amashaya</italic> and mixed with <italic>Rasa Dhatu</italic> causing obstruction of <italic>Rasavaha</italic> and <italic>Swedavaha Srotas</italic> resulting in the destruction of <italic>Agni</italic>; <italic>Agni</italic> then spreads out from its <italic>Sthana</italic> to whole over the body causing the febrile condition [<xref rid="bib21" ref-type="bibr">21</xref>, C.S.Ni.1/20, 23, 26; C.S.Chi.3/129-132].</p></sec><sec id="sec3.2"><label>3.2</label><title>Immunity concept in Ayurveda</title><p id="p0065">Strength, health, lifespan, and vital breath are dependent on the condition of <italic>Agni</italic> [<xref rid="bib21" ref-type="bibr">21</xref>, C.S.Soo. 27/342]. Charaka has mentioned the term <italic>Vyadhikshamatwa</italic> and states that during certain conditions, or due to certain factors, even unwholesome (unhealthy) food does not produce disease immediately; all unwholesome diet are not equally harmful, all dosha are not equally powerful, all persons are not capable of resisting diseases [<xref rid="bib21" ref-type="bibr">21</xref>, C.S.Soo. 28/7]. This suggests that the body&#x02019;s immune system plays a crucial role in disease development. The equilibrium state of <italic>Dhatu</italic> is called <italic>Swasthya</italic> [<xref rid="bib21" ref-type="bibr">21</xref>, C.S.Soo 9/4]. The person who is desirous to be healthy should adopt healthy practices related to diet, conduct, and activities [<xref rid="bib21" ref-type="bibr">21</xref>, C.S.Soo. 7/60]. Thus, Immunity can be considered in Ayurveda as <italic>Vyadhikshamatwa</italic> and <italic>Oja</italic>; which depends on the condition of <italic>Agni</italic>, <italic>Dosha,</italic> and <italic>Dhatu.</italic>
</p><p id="p0070">There are three factors <italic>Aahara, Swapna,</italic> and <italic>Brahmacharya</italic> (diet, sound sleep, and celibacy) that support the life with which the body will be endowed with strength, complexion, and development till life span [<xref rid="bib21" ref-type="bibr">21</xref>, C.S.Soo. 11/35]. <italic>Bala</italic> (&#x0007e; Strength/Immunity) is of three types-congenital, time affected, and acquired. Congenital is that which is developed naturally in the body and mind; time affected is due to seasonal variation and age factor and acquired one is produced by the proper application of diet and exercise [<xref rid="bib21" ref-type="bibr">21</xref>, C.S.Soo. 11/36]. Thus not only diet but also performing yoga or exercises with proper methods by giving rest in between exercises as <italic>Rasayana</italic> therapy will increase acquired strength. [<xref rid="bib21" ref-type="bibr">21</xref>, C.S.Soo.11/36]. Oja is also called Bala; is the essence of all <italic>Sapta Dhatu</italic>, being located in <italic>Hridaya</italic>, combines with Rasa and circulates through the <italic>Dhamani</italic> and performs <italic>Tarpana</italic> or <italic>Prinanam</italic> of the whole body [<xref rid="bib22" ref-type="bibr">22</xref>, S.S.Soo. 15/19; <xref rid="bib21" ref-type="bibr">21</xref>, C.S.17/74]. The equilibrium state of <italic>Kapha</italic> promotes strength, that&#x02019;s why normal <italic>Kapha</italic> is called <italic>Oja</italic>. [<xref rid="bib21" ref-type="bibr">21</xref>, C.S.Soo. 17/117]. Normal pure blood promotes strength, complexion, health, and lifespan [<xref rid="bib21" ref-type="bibr">21</xref>, C.S.Soo. 24/4]. While dealing with <italic>Sannipataja Jwara</italic>, Susruta in <italic>Uttarsthana</italic> mentioned <italic>Abhinyasa Jwara</italic>, also called as <italic>Hataujasa Jwara,</italic> indicating the loss or deranged condition of <italic>Oja</italic> [<xref rid="bib22" ref-type="bibr">22</xref>, S.S.Utt. 39/39-44].</p><p id="p0075">The word &#x02018;<italic>Rasayana</italic> (<italic>Rasa&#x000a0;+&#x000a0;ayana</italic>)&#x02019; refers to nutrition and its transportation in the body for attaining excellent Rasadi <italic>Dhatu</italic>s; which leads to gain longevity, freedom from disorders, optimum strength of physique and sense organs [<xref rid="bib21" ref-type="bibr">21</xref>, C.S.Chi. 1:1/4-8]. <italic>Rasayana</italic> promotes nutrition by explicitly enriching the nutritional value of <italic>Rasa</italic> by enhancing <italic>Agni</italic>, i.e. digestion, metabolism, and absorption (by <italic>Srotashodhana</italic>). Consequently, any medication that improves Rasa&#x02019;s consistency would enhance the health of all body tissues.</p></sec></sec><sec id="sec4"><label>4</label><title>Role of Ayurveda and traditional medicine</title><p id="p0080">Every society has its own medical system, which is deeply rooted in its culture and guided by its philosophy of life. Being culturally and linguistically diverse countries, there developed several types of traditional medicines (TM) based on practices, skill, traditional knowledge based on beliefs, theories, and experiences indigenous to different cultures. Ayurveda, Traditional Chinese medicine (TCM), Ancient Egyptian medicine, Sowa Rigpa, etc. system of medicine remain the most ancient yet living traditions in South East Asia, Western Pacific, Eastern Mediterranean, Africa region. Up to 80 percent of the population in some Asian and African countries depend on TM for primary health care (PHC) needs [<xref rid="bib23" ref-type="bibr">23</xref>]. Still, there is a high trend of using many herbs in religious and cultural works, therapeutically for common ailments and as spices for foods according to occasion specific and seasonal regimes. Ayurveda and TM have made a significant contribution to the prevention and alleviation of various communicable and non-communicable diseases for thousands of years. A long history of using many herbal remedies and experiences passed from generation to generation has resulted in people relying on herbal remedies and some simple home remedies for common diseases can be used even by illiterate citizens. The self-care, an integral part of PHC, with home remedies using various herbs is the most common treatment for India, Nepal, Bhutan, and China for different flu, common cold, fever, GI disorders, etc. Prevention of smallpox in China has been an epoch-making effort in the period of mankind&#x02019;s preventive care. One observational study found that the prevalence between the total number of COVID-19 cases per million population and the grams of spice supply per capita per day is clearly interrelated. Most nations with lower spice intake per capita reported more COVID-19 cases per million population and vice versa [<xref rid="bib24" ref-type="bibr">24</xref>]. Nevertheless, with the invention of drugs, many herbal remedies used historically have become modern medicines. Few notable examples include morphine, digoxin, artemisinin and colchicine. As many herbs are found to have immunomodulatory role and possess antiviral activity, many people are being optimistic over the traditional system of Medicine. Ayurveda and TCM have descriptions of immunomodulation along with anti-viral treatments, even targeted to the coronavirus family [<xref rid="bib2" ref-type="bibr">2</xref>,<xref rid="bib25" ref-type="bibr">25</xref>].</p><p id="p0085">The key factor for COVID-19 to occur and evolve is the interaction between the virus and an individual&#x02019;s immune system [<xref rid="bib26" ref-type="bibr">26</xref>]. As medicinal plants enhance NK cell activity, inhibit activated transcription factor 2 (ATF-2), down-regulate Th17-related cytokines including transcription factor RORc, IL-17A and Th2-related cytokines including IL-5, IL-13, and IL-6, inhibit GATA3, IL-4, IL-6, IL-1&#x003b2;, ROR&#x003b3;t, IL-17A, TNF-&#x003b1; expression and increase the secretions of IL-10, INF-&#x003b3;, etc., it shows that natural products have potent immune-modulatory and immune-boosting effects that may be helpful during the infection course by increasing innate immune response to infections [<xref rid="bib27" ref-type="bibr">27</xref>,<xref rid="bib28" ref-type="bibr">28</xref>].</p></sec><sec id="sec5"><label>5</label><title><italic>Ayush Kwath</italic></title><p id="p0090">Considering the importance of immunity boosting measures in the wake of COVID-19 outbreak, the Ministry of AYUSH, Government of India with the interest of health promotion of the masses, recommends &#x02018;<italic>Ayush Kwath</italic>&#x02019; or &#x02018;<italic>Ayush Kudineer</italic>&#x02019; or &#x02018;<italic>Ayush Joshanda</italic>&#x02019; which comprises of four medicinal herbs (<xref rid="tbl1" ref-type="table">Table&#x000a0;1</xref>
) [<xref rid="bib29" ref-type="bibr">29</xref>,<xref rid="bib30" ref-type="bibr">30</xref>]<bold>.</bold> The herbs like holy basil, cinnamon, ginger, black pepper are highly available, accessible and widely used in the kitchen and are convenient to educate and train about its use to community health workers, community and even to all public that they can have cost-effective treatment with herbal home remedies. This will help to promote immunity and to lower the gatherings at hospitals and pharmacies in this pandemic. This type of public health measure would eventually promote &#x02018;health for all&#x02019; with the theme &#x02018;our health in our own hands&#x02019; making responsible to each and every people by active involvement in their own health instead of relying on mass distribution of some medicine. As people leave their homes to earn a living, this herbal decoction will ensure broad access to health care. The WHO SEARO adopted a resolution to revitalize PHC through health systems strengthening to achieve health for all with the emphasis on health promotion and disease prevention [<xref rid="bib31" ref-type="bibr">31</xref>]. This <italic>Kwath</italic> is not just a mechanical mixture invented for the COVID-19 pandemic, but it is a revival of health tradition.<table-wrap position="float" id="tbl1"><label>Table&#x000a0;1</label><caption><p>Contents and properties of <italic>Ayush Kwath</italic>.</p></caption><alt-text id="alttext0010">Table&#x000a0;1</alt-text><table frame="hsides" rules="groups"><thead><tr><th>S.N</th><th>Name</th><th>Scientific name</th><th>Parts used</th><th>Main chemical constituents</th><th><italic>Rasa</italic></th><th><italic>Virya</italic></th><th>Ayurvedic <italic>Dosha karma</italic></th><th><italic>Sansthanika Karma</italic></th><th>Proportion</th><th>Remarks</th></tr></thead><tbody><tr><td>1.</td><td><italic>Tulsi</italic></td><td><italic>Ocimum sanctum</italic> Linn.</td><td>Leaves</td><td>Volatile oil (Phenol, Aldehyde), Eugenol, Ascorbic acid, Linoleic acid, Carotene</td><td><italic>Katu, Tikta</italic></td><td><italic>Ushna</italic></td><td><italic>Kapha-vatashamaka Pittabardhaka</italic></td><td><italic>Vedanahara, Deepana, Pachana, Anulomana, Krimighna, Hridhya, Raktashodhaka, Kasahara, Swasahara, Kshayanashaka, Mutrala, Vishaghna, Jwaraghna</italic> esp. useful in <italic>Vatashlaishmika, Vishama and Jirna Jwara</italic></td><td>4 parts</td><td><bold><italic>Prabhava</italic></bold> (Special action): <italic>Krimighna</italic></td></tr><tr><td>2.</td><td><italic>Dalchini</italic></td><td><italic>Cinnamomum zeylanicum</italic> Breyn.</td><td>Stem Bark</td><td>Cinnamaldehyde, cuminaldehyde, Eugenol</td><td><italic>Katu, Tikta, Madhura</italic></td><td><italic>Ushna</italic></td><td><italic>Kapha-vatashamaka Pitta vardhaka</italic></td><td><italic>Deepana, Pachana, Vajikarana, Vataanulomana, Yakridutejaka, Grahi, Hriyottejaka, Ojovardhaka, Raktashodhaka, Shelshmahara, Yakshmanashaka, Mutrajanana,</italic></td><td>2 parts</td><td/></tr><tr><td>3.</td><td><italic>Sunthi</italic></td><td><italic>Zingiber officinale</italic> Rosc.</td><td>Rhizome</td><td>Zingiberene, Zingiberol</td><td><italic>Katu</italic></td><td><italic>Ushna</italic></td><td><italic>Kapha-vatashamaka</italic></td><td><italic>Deepana, Pachana, Vrishya, Shoolaprashamana, Raktashodhaka, Hridhyottejaka, Shothahara, Kaphaghna, Swasahara, Jwaraghna, Aampachana</italic></td><td>2 parts</td><td><bold><italic>Prabhava</italic>:</bold><italic>Krimighna</italic><break/><bold>Contraindications</bold>: <italic>Pandu, Kushtha, Mutrakriccha, raktapitta, Grishma and Sharada Ritu</italic></td></tr><tr><td>4.</td><td><italic>Marich</italic></td><td><italic>Piper nigrum</italic> Linn.</td><td>Fruit</td><td>Piperine, Piperidine, Piperettine and Chavicine</td><td><italic>Katu</italic></td><td><italic>Ushna</italic></td><td><italic>Kaphashamaka</italic></td><td><italic>Deepana, Pachana, Yakriduttejaka, Vatanulomana, Krimighna, Hriddhyottejaka, Kaphaghna, Kaphamissaraka, Jwaraghna,</italic> esp. <italic>Vishamjwara pratibandhaka</italic>.</td><td>1 part</td><td/></tr></tbody></table></table-wrap></p><p id="p0095">
<bold>Method of preparation and use:</bold>
</p><p id="p0100">Take all the ingredients in dry form as per standards laid down in Ayurvedic Pharmacopoeia and make coarse powder. Make sachets or tea bags each of 3&#x000a0;g of powder or 500&#x000a0;mg tablet of aqueous extract, to be consumed like tea or hot drink by dissolving in 150&#x000a0;ml of boiled water, once or twice daily. <italic>Gud</italic> (Jaggery)/<italic>Draksha</italic> (Resins) and/or Lemon Juice can be added while consuming the formulation.</p><sec id="sec5.1"><label>5.1</label><title>Tulsi</title><p id="p0105">Many in-vitro, animal and human experimental scientific studies showed that; due to presence of eugenol, phenolic compounds, linoleic acid, etc. compounds <italic>Tulsi</italic> has antimicrobial (including antibacterial, antiviral, antimalarial), anti-diarrheal, anti-oxidant, anti-inflammatory, hepato-protective, cardio-protective, reno-protective, analgesic, antipyretic, immune-modulatory properties and is thus recommended as a treatment for a range of diseases including features like cough, fever, asthma, anxiety, diarrhea, gastric, cardiac and genitourinary disorders [<xref rid="bib32" ref-type="bibr">[32]</xref>, <xref rid="bib33" ref-type="bibr">[33]</xref>, <xref rid="bib34" ref-type="bibr">[34]</xref>, <xref rid="bib35" ref-type="bibr">[35]</xref>, <xref rid="bib36" ref-type="bibr">[36]</xref>]. Due to its anti-inflammatory and antioxidant properties, it protects against toxic chemical-induced injury, enhance the antioxidant enzymes and protect cellular organelles and membranes by clearing damaged free radicals [<xref rid="bib37" ref-type="bibr">37</xref>].</p><p id="p0110">The compounds such as ursolic acid, carnosol, rosmarinic acid, cirsilineol, apigenin, eugenol, and cirsimaritin present in <italic>O</italic>
<italic>.</italic>
<italic>sanctum</italic> increase haemoglobin concentration, enhance SRBC agglutinin titers, decrease cyclo-oxygenase (CoX)-2 and lipoxygenase (LOX)-5 enzymes activity, suppress NF-&#x003ba;B classical pathway, up regulation of IL-2, IFN-&#x003b3; and TNF-&#x003b1;, down regulation of IL-1&#x003b2; and produce of SRBC antigen-specific antibodies, which represent a major defense mechanism to assess T-cell-dependent antibody responses i.e. <italic>Tulsi</italic> by enhancing immune response boost the defense mechanism against the infection [<xref rid="bib38" ref-type="bibr">[38]</xref>, <xref rid="bib39" ref-type="bibr">[39]</xref>, <xref rid="bib40" ref-type="bibr">[40]</xref>]. Several studies have shown that <italic>Tulsi</italic> (aqueous and methanol extract of leaf and seed oil) besides improving vital capacity also is an immune-modulator and regulator as it enhances immune response by increasing T-helper and NK cells; phagocytic activity and index with the rise in lymphocyte count, neutrophil count and antibody titer [<xref rid="bib35" ref-type="bibr">35</xref>,<xref rid="bib41" ref-type="bibr">41</xref>].</p><p id="p0115">In an acute toxicity study, it did not produce any hazardous symptoms or CNS and ANS toxicities or death and did not show any change in water and food consumption, body weight, and hematological and biochemical profiles [<xref rid="bib42" ref-type="bibr">42</xref>].</p></sec><sec id="sec5.2"><label>5.2</label><title>Dalchini</title><p id="p0120">It is a potent immune system booster and is used in various ailments like flu, indigestion, edema, cough, etc. [<xref rid="bib43" ref-type="bibr">43</xref>,<xref rid="bib44" ref-type="bibr">44</xref>]. Cinnamon bark contains cinnamaldehyde, benzaldehyde, cuminaldehyde and terpenes [<xref rid="bib45" ref-type="bibr">45</xref>]. In one study, cinnamon at high dose (100&#x000a0;mg/kg) showed immune-stimulant activity as it significantly increased the phagocytic index, serum immunoglobulin levels and antibody titer and decreased the percentage reductions in neutrophil count. Cinnamon low dose (10&#x000a0;mg/kg) increased serum immunoglobulin levels only. This showed that high dose increases both cell mediated and humoral immunity whereas low dose showed effect only on humoral immunity [<xref rid="bib44" ref-type="bibr">44</xref>]. The studies also suggest that cinnamaldehyde can act as a strong regulator of monocyte/macrophage-mediated immune responses by inhibition of PI3K, PDK1 and NF-&#x003ba;B activation of signaling components. In addition to this, by the activation of CD29 and CD43, it blocked cell migration cell&#x02013;cell adhesion induced but not cell-fibronectin adhesion and it was able to suppress both the production of nitric oxide (NO) and up regulation of surface levels of co-stimulatory molecules (CD69 and CD80) and pattern recognition receptors (TLR2 and CR3) [<xref rid="bib46" ref-type="bibr">46</xref>].</p><p id="p0125">Cinnamon bark decrease systemic levels of IFN-&#x003b3; without altering the levels of IL-4 or IL-2, inhibit anti-CD3 Ab-stimulated IFN-&#x003b3; and IL-4 at the mRNA and secreted protein levels, enhance IL-2 protein secretion at the cellular level which helps to decrease cell death, inhibit IL-2mRNA expression, inhibit anti-CD3-induced p38, JNK, ERK1/2, and STAT4 activation, but not I&#x003ba;B&#x003b1; degradation or STAT6 and ultimately alter the inflammatory responses in T cells. This shows the immune-modulatory effect of cinnamon on cytokine secretion and the involvement of intracellular signaling molecules in activated T cells. It also causes a reduction in the sub-G1 phase, accompanied by an increased ratio of apoptotic cells to necrotic cells [<xref rid="bib47" ref-type="bibr">47</xref>]. The constituents like cinnamaldehyde, cinnamophilin etc are found to be a thromboxane A2 receptor antagonist, anticoagulative, anti-atherosclerotic and thus prevents unnecessary clumping of platelets and atherosclerotic CVD [<xref rid="bib48" ref-type="bibr">48</xref>].</p><p id="p0130">In a systematic review of its adverse events, relatively few self-limiting adverse effects were reported like allergic reactions and gastrointestinal disorders on clinical trials, case reports and case series. The evidence available show that cinnamon is safe for use as spice in daily diets or as a medication [<xref rid="bib49" ref-type="bibr">49</xref>]. However, its use for therapeutic reasons, in high doses or for prolonged periods, can cause some adverse effects and should be observed clinically.</p></sec><sec id="sec5.3"><label>5.3</label><title>Sunthi</title><p id="p0135">An alcohol extract increases the immunological status of mice with increased phagocytosis by macrophages whereas crude extract was also shown to increase humoral and cell-mediated immune responses [<xref rid="bib27" ref-type="bibr">27</xref>]. The bioactive compounds of ginger such as nevirapine, &#x003b2;-sitosterol, 6-gingediol, germacrene, methyl-6-shogaol, 6-gingerol, &#x003b1;-linalool, 6-shogaol, gingerdion, zingiberene, etc., are known to inhibit viral replication; among these the most potent inhibitors of reverse transcriptase (RT) enzyme is &#x003b2;-sitosterol, which is predicted to be used as non-nucleoside reverse transcriptase (NNRTIs) HIV-1 inhibitors [<xref rid="bib50" ref-type="bibr">50</xref>,<xref rid="bib51" ref-type="bibr">51</xref>]. It is reported that Ginger contains TNF-&#x003b1; which is also known as an anti-influenza cytokine [<xref rid="bib52" ref-type="bibr">52</xref>]. The rhizome of Ginger and its main components like gingerols, shogaols, etc inhibit prostaglandin and leukotriene biosynthesis, inhibit cyclooxygenase and lipoxygenase activities, inhibits the synthesis of pro-inflammatory cytokines such as IL-1, TNF-&#x003b1;, and IL-8 without any significant effect in IL-6 levels; inhibit the excessive production of NO, PGE (2), TNF-&#x003b1;, and IL-1beta, reduce the elevated expression of NF&#x003ba;B and TNF-&#x003b1;, down-regulate inflammatory iNOS and COX-2 gene expression, inhibit thromboxane synthetase, raise levels of prostacyclin without a concomitant rise in PGE 2 or PGE 2 alpha, inhibit platelet aggregation, decrease age-related oxidative stress markers and enhance fibrinolysis [<xref rid="bib53" ref-type="bibr">[53]</xref>, <xref rid="bib54" ref-type="bibr">[54]</xref>, <xref rid="bib55" ref-type="bibr">[55]</xref>, <xref rid="bib56" ref-type="bibr">[56]</xref>, <xref rid="bib57" ref-type="bibr">[57]</xref>, <xref rid="bib58" ref-type="bibr">[58]</xref>].</p><p id="p0140">The concentration of IgM and eosinophil count in non-smokers was significantly increased in a comparative study of the effect of ginger extract among male smokers and non-smokers, whereas the concentration of hemoglobin and lymphocyte count in smokers was strongly increased. This indicates that in non-smokers, ginger results in a stronger antibody response or humoral immunity than in smokers [<xref rid="bib59" ref-type="bibr">59</xref>].</p><p id="p0145">According to Ayurveda, it is contraindicated to be used in a few diseases: <italic>Kushtha, Pandu, Mutrakriccha, Raktapitta</italic>; and in <italic>Grishma</italic> (summer) and <italic>Sharada</italic> (autumn) <italic>Ritu</italic>. There are few minor adverse effects recorded that did not need care, such as mild gastrointestinal symptoms, sleepiness, mild diarrhea during prior few days of treatment. It is also explained that ginger has the ability to induce heartburn and as a gastric irritant with doses above 6&#x000a0;g [<xref rid="bib60" ref-type="bibr">60</xref>]. During pregnancy, ginger did not pose a major risk for side effects or adverse events [<xref rid="bib61" ref-type="bibr">61</xref>].</p></sec><sec id="sec5.4"><label>5.4</label><title>Marich</title><p id="p0150">It has been also found to increase bioavailability, thus enhance the therapeutic efficacy of many drugs, vaccines and nutrients and have immune-modulatory, anti-oxidant, antiplatelets, antihypertensive, anti-asthmatic, antipyretic, analgesic, anti-carcinogenic, anti-inflammatory, anti-diarrheal, antispasmodic, anxiolytic, antidepressants, hepatoprotective, anti-ulcer, anti-thyroids, anti-apoptotic, anti-metastatic, antimutagenic, antibacterial, antifungal and anti-amoebic properties [<xref rid="bib62" ref-type="bibr">[62]</xref>, <xref rid="bib63" ref-type="bibr">[63]</xref>, <xref rid="bib64" ref-type="bibr">[64]</xref>, <xref rid="bib65" ref-type="bibr">[65]</xref>]. The extract and its constituents like piperine, regulate the balance of the cytokines production of Th1, Th2, Th17, and Treg cells, reduce the accumulation of inflammatory cells, inhibit the expressions of GATA3, IL-4, IL-6, IL-1&#x003b2;, ROR&#x003b3;t, IL-17A and TNF-&#x003b1;, increase INF-&#x003b3; and IL-10 secretions in BALF (Broncho-alveolar lavage fluid) and increase macrophage activation and T and B cell proliferation [<xref rid="bib63" ref-type="bibr">63</xref>,<xref rid="bib66" ref-type="bibr">66</xref>].</p><p id="p0155">Beside this, <italic>Marich</italic> possess cytotoxic activity, suppresses the levels of total IgE, anti-OVA IgE, anti-OVA IgG1 and histamine release in serum, ameliorates fibrosis and infiltration of inflammatory cells, inhibits the allergic responses, inhibitsTh2/Th17 responses and mast cells activation, inhibits NF-&#x003ba;B, c-Fos, cAMP response element-binding (CREB) and activated transcription factor 2 (ATF-2); suppresses PMA-induced MMP-9 expression, inhibits PKC&#x003b1;/extracellular signal-regulated kinase (ERK) 1/2 and reduces NF-&#x003ba;B/AP-1 activation. In addition, piperine also inhibits the P-glycoprotein (P-gp) and CYP3A4 functions [<xref rid="bib67" ref-type="bibr">[67]</xref>, <xref rid="bib68" ref-type="bibr">[68]</xref>, <xref rid="bib69" ref-type="bibr">[69]</xref>]. <italic>Piper nigrum</italic> is found to have dose dependent antifertility effects on mice [<xref rid="bib70" ref-type="bibr">70</xref>].</p></sec></sec><sec id="sec6"><label>6</label><title>Discussion</title><p id="p0160">According to Ayurveda, therapeutics is of two types: 1. <italic>Swasthasyorjaskara</italic>-which promotes strength (immunity) in the healthy and 2. <italic>Roganut</italic>-which alleviates disorders. Both of these groups perform both of these functions but <italic>Rasayana</italic> and <italic>Vajikarana</italic> are mostly used for promotive treatment (C.S.Chi. 1:1/4-8) [<xref rid="bib21" ref-type="bibr">21</xref>]. <italic>Ayush Kwath</italic> has both immune promoting and disease alleviating properties which can be achieved by various treatment modalities like <italic>Rasayana, Satwawajaya, Yuktivyapashraya, Vyadhi Viparitarthakari chikitsa,</italic> etc.</p><p id="p0165">The <italic>Katu</italic> and <italic>Tikta Rasa, Usna Virya</italic> and <italic>Deepana, Pachana, Yakriduttejaka</italic> properties of <italic>Ayush Kwath</italic> help to improve <italic>Agni</italic> and <italic>Srotosodhana</italic> (improves microcirculation and tissue perforation); thus promotes proper digestion, metabolism, and absorption and acts as <italic>Rasayana</italic> for the development of preceding <italic>Dhatu</italic> and finally form <italic>Oja</italic>. <italic>Oja</italic> itself acts as immunity to prevent disease. Immunity is dependent on the condition of <italic>Agni</italic>. <italic>Ayush Kwath</italic> with its <italic>Agni</italic> promoting and <italic>Kaphashamaka</italic> properties balance <italic>Kapha;</italic> and with <italic>Raktashodhaka, Hridhya, Krimighna</italic> properties purify the blood. It is already mentioned that natural <italic>Kapha</italic> and pure blood promote <italic>Oja</italic> and <italic>Bala</italic> respectively. <italic>Krimighna</italic> is the <italic>Prabhava</italic> (special action) of <italic>Tulsi</italic> and <italic>Sunthi</italic> which directly acts against pathogens. The properties like <italic>Jwaraghna</italic> (esp. <italic>Vatashlaishmika, Vishama</italic>), <italic>Kasahara, Swasahara, Kshayanashaka, Shoolaprashamana, Swothahara, Kaphaghna, Hridayaottejaka, Yakridutejaka</italic> have direct role to alleviate various clinical signs, symptoms and complications.</p><p id="p0170">As this disease is considered as <italic>Kapha-Vatolvana Hina Pitta Sannipataja Jwara, the Kapha Vata Shamaka</italic> properties of <italic>Ayush Kwath</italic> can play a significant role in balancing the vitiated doshas. After six days of <italic>Jwara, Charaka</italic> suggests the decoction of <italic>Pachana</italic> drugs in the case of <italic>Amdosha</italic> and <italic>Shamaniya</italic> drugs in <italic>Niramadosha</italic> [<xref rid="bib21" ref-type="bibr">21</xref>, C.S.Chi. 3/160]. This shows that <italic>Yuktivyapashraya</italic> and <italic>Vyadhiviparita</italic> chikitsa can be done even after the involvement of <italic>Dosha</italic> in later stages. <italic>Ayush Kwath</italic> has potential psycho-neuro-immune mechanisms via evidence of a reduction in depression, anxiety, and stress in controlled trials and shows meaning response as it is a specific remedy for cough and respiratory problems; this shows the role of <italic>Satvawajaya Chikitsa</italic> in its management [<xref rid="bib71" ref-type="bibr">71</xref>].</p><p id="p0175">Immunity plays a key role in the pathogenesis of COVID-19 both during the early non-severe stage and during the severe stage of the disease. The early-stage strong immune response may prevent the propagation and spread of viruses inside the body thus reducing the severity of cases and early termination of infection. While during later stage, strong cell-mediated immunity of the body against the virus itself can be a factor responsible for grave consequences due to cytokine storm. The target during the early stage should be to reduce viral propagation, while at a later stage should be to reduce the inflammatory response of the immune system. Medicinal herbs with immune booster property can be an option during the early non-severe stage while herbs with anti-inflammatory and anti-thrombotic properties can be an option during a later or severe stage. Cytokine storm that is believed as a major factor responsible for complications and death of COVID-19 patients has been found to be reduced with anti-inflammatory drugs like steroids and IL-6 receptor antagonists, Anti-inflammatory interleukins (IL-10) in modern medicine [<xref rid="bib72" ref-type="bibr">72</xref>]. The role of medicinal herbs with anti-inflammatory property on the cytokine storm is still lacking in research. Like anti-inflammatory interleukins and IL-6 receptor antagonist (Tocilizumab); IL 10 that are proposed in modern medicine to have a therapeutic role in the reduction of severity and mortality of COVID-19. Cinnamon bark that is found to decrease INF-&#x003b3; and IL-4, Its anti-atherosclerotic, anti-coagulative and anti-platelet activity can be a topic of research to reduce inflammatory and thrombotic complications in COVID-19 patients. <italic>Sunthi</italic> due to its inhibitory effects on pro-inflammatory cytokines and <italic>Marich</italic> with its property of reducing the accumulation of inflammatory cells with controlled cytokine production balance can be an option to reduce cytokine storm in COVID-19 patients and need to be researched with the therapeutic trial.</p><p id="p0180">Each herbal constituent of <italic>Ayush Kwath</italic> is found to have some role in increasing the immune response. On correlating immune-pathogenesis of COVID-19 with immune-modulatory effects of herbs, <italic>Ayush Kwath</italic> can be an option before infection and during the non-severe stage to enhance immune response, prevent the propagation of COVID-19 virus to lower airways and thus help in early recovery with mild symptoms. Pharmacodynamics and pharmacokinetics of this polyherbal formulation (PHF) is not yet studied, but it is believed that the pharmacological agents or the active principles of PHF may exert potentiating, synergistic, agonistic antagonistic actions resulting maximum therapeutic efficacy with minimal side effects [<xref rid="bib73" ref-type="bibr">73</xref>,<xref rid="bib74" ref-type="bibr">74</xref>].</p><p id="p0185">The dose of each herb is mentioned in API (The Ayurvedic Pharmacopoeia of India) as 2&#x02013;3&#x000a0;g powder of <italic>Tulsi</italic> leaves, 1&#x02013;3&#x000a0;g powder of cinnamon bark, 250&#x000a0;mg&#x02013;1&#x000a0;g powder form of black pepper, and 1&#x02013;2&#x000a0;g powder of ginger [<xref rid="bib75" ref-type="bibr">75</xref>].</p><p id="p0190">According to Ayurveda, on the basis of predominance of dosha, every person has their own different constituent, and every season and the place have their identical role over the person&#x02019;s <italic>Prakriti</italic>. According to Ayurveda, <italic>Tikshna</italic> properties can stimulate the urinary system thus increasing urine, and can cause sweating [<xref rid="bib30" ref-type="bibr">30</xref>]. As these drugs have <italic>Laghu</italic> and <italic>Tikshna</italic> properties, they can cause <italic>Srotoshodhana</italic>, thus can increase urination and defecation in higher doses. Due to <italic>Usna Virya</italic>, it can cause <italic>Pitta Vriddhi Lakshan</italic> like hyperacidity, hot or burning sensation, excessive sweating, fatigue, loss of taste and sleep disturbances. Ginger is contraindicated in the summer and autumn season. It is mentioned that <italic>Chandraprabhavati</italic>, which contains <italic>Sunthi, Marich</italic> and <italic>Dalchini</italic>, clears fluid and <italic>Kapha</italic> from <italic>Mutravaha Srotas</italic> and <italic>Ambuvaha Srotas</italic>; this excess of fluid can cause cystitis, burning, and painful urination. There may be too high content of sugar and albumin in the urine [<xref rid="bib76" ref-type="bibr">76</xref>].These drugs seemed to increase <italic>Pitta</italic>, tend to have some adverse effects such as headache, sleepiness, mild diarrhea, etc. Also, there may be hypo or hyper immune sensitivity of this formulation or occurrence of chemical incompatibility due to many chemical constituents [<xref rid="bib77" ref-type="bibr">77</xref>]. Though the maximum use of each herbs traditionally for a long time ensures that these herbs are safe but it is essential to determine dosage of PHF for adults and pediatrics in the form of bodyweight or dosage per kg and according to severity of disease, the person&#x02019;s <italic>Prakriti</italic> and his/her residing climate and region. Thus, this formulation must be evaluated using scientific methods to understand bioactive compounds responsible, their mechanism of action, and ways to regulate the activity of these compounds on COVID-19 related immunological factors. Toxicological studies and clinical trials must be done before its extensive usage.</p></sec><sec id="sec7"><label>7</label><title>Conclusion</title><p id="p0195">With various Ayurveda concepts and biomolecular studies, these Ayurveda herbs are seen to have rich sources to fight against the immuno-pathogenesis process of viral diseases, but to date, no study has been found about its effectiveness against COVID-19. <italic>Ayush Kwath</italic> due to its antiviral, immune-modulatory, antioxidant, anti-inflammatory, anti-platelet, anti-atherosclerotic, hepato-protective, reno-protective properties; seems to be effective in regulating immunity for the prevention and reduction of viral disease complications. As there is lack of enough evidence to support its specific role against coronavirus, there is a requirement to validate the effectiveness of these formulations with extensive biotechnological, pharmacological, and clinical research.</p></sec><sec id="sec8"><title>Source of funding</title><p id="p0200">This work did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.</p></sec><sec sec-type="COI-statement"><title>Conflicts of interest</title><p id="p0205">None.</p></sec></body><back><ref-list id="cebib0010"><title>References</title><ref id="bib1"><label>1</label><element-citation publication-type="journal" id="sref1"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>P.</given-names></name><name><surname>Yang</surname><given-names>X.-L.</given-names></name><name><surname>Wang</surname><given-names>X.-G.</given-names></name><name><surname>Hu</surname><given-names>B.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name></person-group><article-title>A&#x000a0;pneumonia outbreak associated with a new coronavirus of probable bat origin</article-title><source>Nature</source><volume>579</volume><year>2020</year><fpage>270</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2012-7</pub-id><pub-id pub-id-type="pmid">32015507</pub-id></element-citation></ref><ref id="bib2"><label>2</label><element-citation publication-type="journal" id="sref2"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>L.T.</given-names></name><name><surname>Hsu</surname><given-names>W.C.</given-names></name><name><surname>Lin</surname><given-names>C.C.</given-names></name></person-group><article-title>Antiviral natural products and herbal medicines</article-title><source>J&#x000a0;Trad Compliment Med</source><volume>4</volume><year>2014</year><fpage>24</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.4103/2225-4110.124335</pub-id></element-citation></ref><ref id="bib3"><label>3</label><element-citation publication-type="journal" id="sref3"><person-group person-group-type="author"><name><surname>Abdulamir</surname><given-names>A.S.</given-names></name><name><surname>Hafidh</surname><given-names>R.R.</given-names></name></person-group><article-title>The possible immunological pathways for the variable immunopathogenesis of COVID-19 infections among healthy adults, elderly and children</article-title><source>Electr J Gen Med</source><volume>17</volume><year>2020</year><fpage>1</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.29333/ejgm/7850</pub-id></element-citation></ref><ref id="bib4"><label>4</label><element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>H.</given-names></name><name><surname>Zhong</surname><given-names>L.</given-names></name><name><surname>Deng</surname><given-names>J.</given-names></name><name><surname>Peng</surname><given-names>J.</given-names></name><name><surname>Dan</surname><given-names>H.</given-names></name><name><surname>Zeng</surname><given-names>X.</given-names></name></person-group><article-title>High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa</article-title><source>Int J Oral Sci</source><volume>12</volume><year>2020</year><fpage>8</fpage><pub-id pub-id-type="doi">10.1038/s41368-020-0074-x</pub-id><pub-id pub-id-type="pmid">32094336</pub-id></element-citation></ref><ref id="bib5"><label>5</label><element-citation publication-type="journal" id="sref5"><person-group person-group-type="author"><name><surname>Donoghue</surname><given-names>M.</given-names></name><name><surname>Hsieh</surname><given-names>F.</given-names></name><name><surname>Baronas</surname><given-names>E.</given-names></name><name><surname>Godbout</surname><given-names>K.</given-names></name><name><surname>Gosselin</surname><given-names>M.</given-names></name><name><surname>Stagliano</surname><given-names>N.</given-names></name></person-group><article-title>A&#x000a0;novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9</article-title><source>Circ Res</source><volume>87</volume><year>2000</year><fpage>E1</fpage><lpage>E9</lpage><pub-id pub-id-type="doi">10.1161/01.res.87.5.e1</pub-id><pub-id pub-id-type="pmid">10969042</pub-id></element-citation></ref><ref id="bib6"><label>6</label><element-citation publication-type="journal" id="sref6"><person-group person-group-type="author"><name><surname>Cruz</surname><given-names>A.T.</given-names></name><name><surname>Zeichner</surname><given-names>S.L.</given-names></name></person-group><article-title>COVID-19 in children: initial characterization of the pediatric disease</article-title><source>Pediatrics</source><year>2020</year><pub-id pub-id-type="doi">10.1542/peds.2020-0834</pub-id></element-citation></ref><ref id="bib7"><label>7</label><element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Q.</given-names></name><name><surname>Guan</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>P.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Zhou</surname><given-names>L.</given-names></name><name><surname>Tong</surname><given-names>Y.</given-names></name></person-group><article-title>Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia</article-title><source>N&#x000a0;Engl J Med</source><volume>382</volume><year>2020</year><fpage>1199</fpage><lpage>1207</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa2001316</pub-id><pub-id pub-id-type="pmid">31995857</pub-id></element-citation></ref><ref id="bib8"><label>8</label><element-citation publication-type="journal" id="sref8"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Gayle</surname><given-names>A.A.</given-names></name><name><surname>Wilder-Smith</surname><given-names>A.</given-names></name><name><surname>Rockl&#x000f6;v</surname><given-names>J.</given-names></name></person-group><article-title>The reproductive number of COVID-19 is higher compared to SARS coronavirus</article-title><source>J&#x000a0;Trav Med</source><volume>27</volume><year>2020</year><pub-id pub-id-type="doi">10.1093/jtm/taaa021</pub-id></element-citation></ref><ref id="bib9"><label>9</label><element-citation publication-type="journal" id="sref9"><person-group person-group-type="author"><name><surname>Porter</surname><given-names>D.D.</given-names></name></person-group><article-title>Destruction of virus-infected cells by immunological mechanisms</article-title><source>Annu Rev Microbiol</source><volume>25</volume><year>1971</year><fpage>283</fpage><lpage>290</lpage><pub-id pub-id-type="doi">10.1146/annurev.mi.25.100171.001435</pub-id><pub-id pub-id-type="pmid">5005028</pub-id></element-citation></ref><ref id="bib10"><label>10</label><element-citation publication-type="journal" id="sref10"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>R.</given-names></name><name><surname>Zhao</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Niu</surname><given-names>P.</given-names></name><name><surname>Yang</surname><given-names>B.</given-names></name><name><surname>Wu</surname><given-names>H.</given-names></name></person-group><article-title>Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding</article-title><source>Lancet</source><volume>395</volume><issue>10224</issue><year>2020</year><fpage>565</fpage><lpage>574</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(20)30251-8</pub-id><pub-id pub-id-type="pmid">32007145</pub-id></element-citation></ref><ref id="bib11"><label>11</label><element-citation publication-type="journal" id="sref11"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>K.</given-names></name><name><surname>Fang</surname><given-names>Y.Y.</given-names></name><name><surname>Deng</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>M.F.</given-names></name><name><surname>Ma</surname><given-names>J.P.</given-names></name></person-group><article-title>Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province</article-title><source>Chin Med J (Engl)</source><volume>133</volume><issue>9</issue><year>2020</year><fpage>1025-1031</fpage><pub-id pub-id-type="doi">10.1097/CM9.0000000000000744</pub-id><pub-id pub-id-type="pmid">32044814</pub-id></element-citation></ref><ref id="bib12"><label>12</label><element-citation publication-type="journal" id="sref12"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Shao</surname><given-names>C.</given-names></name><name><surname>Huang</surname><given-names>J.</given-names></name><name><surname>Gan</surname><given-names>J.</given-names></name><name><surname>Huang</surname><given-names>X.</given-names></name></person-group><article-title>COVID-19 infection: the perspectives on immune responses</article-title><source>Cell Death Differ</source><volume>27</volume><year>2020</year><fpage>1451</fpage><lpage>1454</lpage><pub-id pub-id-type="doi">10.1038/s41418-020-0530-3</pub-id><pub-id pub-id-type="pmid">32205856</pub-id></element-citation></ref><ref id="bib13"><label>13</label><element-citation publication-type="book" id="sref13"><person-group person-group-type="author"><name><surname>De Wilde</surname><given-names>A.H.</given-names></name><name><surname>Snijder</surname><given-names>E.J.</given-names></name><name><surname>Kikkert</surname><given-names>M.</given-names></name><name><surname>van Hemert</surname><given-names>M.J.</given-names></name></person-group><chapter-title>Host factors in coronavirus replication</chapter-title><person-group person-group-type="editor"><name><surname>Tripp</surname><given-names>R.</given-names></name><name><surname>Tompkins</surname><given-names>S.</given-names></name></person-group><series>Roles of host gene and non-coding RNA expression in virus infection. Current topics in microbiology and immunology</series><volume>vol. 419</volume><year>2020</year><publisher-name>Springer</publisher-name><publisher-loc>Cham</publisher-loc><comment>Available from:</comment><ext-link ext-link-type="uri" xlink:href="https://link.springer.com/chapter/10.1007/82_2017_25" id="intref0010">https://link.springer.com/chapter/10.1007/82_2017_25</ext-link></element-citation></ref><ref id="bib14"><label>14</label><element-citation publication-type="journal" id="sref14"><person-group person-group-type="author"><name><surname>Bonavia</surname><given-names>A.</given-names></name><name><surname>Zelus</surname><given-names>B.D.</given-names></name><name><surname>Wentworth</surname><given-names>D.E.</given-names></name><name><surname>Talbot</surname><given-names>P.J.</given-names></name><name><surname>Holmes</surname><given-names>K.V.</given-names></name></person-group><article-title>Identification of a receptor-binding domain of the spike glycoprotein of human coronavirus HCoV-229E</article-title><source>J&#x000a0;Virol</source><volume>77</volume><year>2003</year><fpage>2530</fpage><lpage>2538</lpage><pub-id pub-id-type="doi">10.1128/jvi.77.4.2530-2538.2003</pub-id><pub-id pub-id-type="pmid">12551991</pub-id></element-citation></ref><ref id="bib15"><label>15</label><element-citation publication-type="book" id="sref15"><person-group person-group-type="author"><name><surname>Klimpel</surname><given-names>G.R.</given-names></name></person-group><chapter-title>Immune defenses</chapter-title><person-group person-group-type="editor"><name><surname>Baron</surname><given-names>S.</given-names></name></person-group><source>Medical microbiology</source><edition>4th ed.</edition><year>1996</year><publisher-name>University of Texas Medical Branch at Galveston</publisher-name><publisher-loc>Galveston (TX)</publisher-loc><comment>[Chapter 50]. Available from:</comment><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK8423/?fbclid=IwAR2C3XNFoeVkq2PS-B_LGg7bfuriyW9jt5NGHC3FXOHYVaOs2Z9DCZTD-xc" id="intref0015">https://www.ncbi.nlm.nih.gov/books/NBK8423/?fbclid=IwAR2C3XNFoeVkq2PS-B_LGg7bfuriyW9jt5NGHC3FXOHYVaOs2Z9DCZTD-xc</ext-link></element-citation></ref><ref id="bib16"><label>16</label><element-citation publication-type="journal" id="sref16"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>A.E.</given-names></name><name><surname>Chambers</surname><given-names>R.C.</given-names></name></person-group><article-title>The mercurial nature of neutrophils: still an enigma in ARDS?</article-title><source>Am J Physiol Lung Cell Mol Physiol</source><volume>306</volume><year>2014</year><fpage>L217</fpage><lpage>L230</lpage><pub-id pub-id-type="doi">10.1152/ajplung.00311.2013</pub-id><pub-id pub-id-type="pmid">24318116</pub-id></element-citation></ref><ref id="bib17"><label>17</label><element-citation publication-type="journal" id="sref17"><person-group person-group-type="author"><name><surname>Cameron</surname><given-names>M.J.</given-names></name><name><surname>Bermejo-Martin</surname><given-names>J.F.</given-names></name><name><surname>Danesh</surname><given-names>A.</given-names></name><name><surname>Muller</surname><given-names>M.P.</given-names></name><name><surname>Kelvin</surname><given-names>D.J.</given-names></name></person-group><article-title>Human immunopathogenesis of severe acute respiratory syndrome (SARS)</article-title><source>Virus Res</source><volume>133</volume><year>2008</year><fpage>13</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1016/j.virusres.2007.02.014</pub-id><pub-id pub-id-type="pmid">17374415</pub-id></element-citation></ref><ref id="bib18"><label>18</label><element-citation publication-type="journal" id="sref18"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>H.</given-names></name><name><surname>Ji</surname><given-names>W.</given-names></name><name><surname>Wu</surname><given-names>W.</given-names></name><name><surname>Chen</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name></person-group><article-title>Virology, epidemiology, pathogenesis, and control of COVID-19</article-title><source>Viruses</source><volume>12</volume><year>2020</year><pub-id pub-id-type="doi">10.3390/v12040372</pub-id></element-citation></ref><ref id="bib19"><label>19</label><element-citation publication-type="journal" id="sref19"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Wu</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>J.-W.</given-names></name><name><surname>Zhao</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>G.-Q.</given-names></name></person-group><article-title>The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality</article-title><source>Int J Antimicrob Agents</source><year>2020</year><fpage>105954</fpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2020.105954</pub-id><pub-id pub-id-type="pmid">32234467</pub-id></element-citation></ref><ref id="bib20"><label>20</label><element-citation publication-type="journal" id="sref20"><person-group person-group-type="author"><name><surname>Klok</surname><given-names>F.A.</given-names></name><name><surname>Kruip</surname><given-names>M.J.H.A.</given-names></name><name><surname>van der Meer</surname><given-names>N.J.M.</given-names></name><name><surname>Arbous</surname><given-names>M.S.</given-names></name><name><surname>Gommers</surname><given-names>D.A.M.P.J.</given-names></name><name><surname>Kant</surname><given-names>K.M.</given-names></name></person-group><article-title>Incidence of thrombotic complications in critically ill ICU patients with COVID-19</article-title><source>Thromb Res</source><year>2020</year><pub-id pub-id-type="doi">10.1016/j.thromres.2020.04.013</pub-id></element-citation></ref><ref id="bib21"><label>21</label><element-citation publication-type="book" id="sref21"><person-group person-group-type="editor"><name><surname>Dwivedi</surname><given-names>L.</given-names></name><name><surname>Dwivedi</surname><given-names>B.K.</given-names></name><name><surname>Goswami</surname><given-names>P.K.</given-names></name></person-group><source>Caraka Samhita of Maharshi Agnivesa with Ayurvedadipika Sanskrit commentary by Sri Cakrapanidatta, Tattvaprakasini Hindi commentary of Ayurvedadipika and on some places Hindi commentary of Jalpakalpataru of Gangadhar</source><edition>4th ed.</edition><year>2017</year><publisher-name>Chowkhamba Krishnadas Academy</publisher-name><publisher-loc>Varanasi</publisher-loc></element-citation></ref><ref id="bib22"><label>22</label><element-citation publication-type="book" id="sref22"><person-group person-group-type="author"><name><surname>Thakaral</surname><given-names>K.K.</given-names></name></person-group><chapter-title>Susruta Samhita of Shree Susruta, elaboration of Nibandhasangraha of Shree Dalhan and Nyachandrika of shree Gayadasa</chapter-title><comment>(revised ed.)</comment><year>2016</year><publisher-name>Chaukhambha Orientalia</publisher-name><publisher-loc>Varanasi</publisher-loc></element-citation></ref><ref id="bib23"><label>23</label><element-citation publication-type="book" id="sref23"><person-group person-group-type="author"><collab>World Health Organization, Regional Office for South-East Asia</collab></person-group><chapter-title>Traditional herbal remedies for primary health care</chapter-title><year>2010</year><publisher-name>WHO Regional Office for South-East Asia</publisher-name><ext-link ext-link-type="uri" xlink:href="https://apps.who.int/iris/handle/10665/206024" id="intref0020">https://apps.who.int/iris/handle/10665/206024</ext-link></element-citation></ref><ref id="bib24"><label>24</label><element-citation publication-type="journal" id="sref24"><person-group person-group-type="author"><name><surname>Elsayed</surname><given-names>Y.</given-names></name><name><surname>Khan</surname><given-names>N.A.</given-names></name></person-group><article-title>Immunity-boosting spices and the novel coronavirus</article-title><source>ACS Chem Neurosci</source><volume>11</volume><issue>12</issue><year>2020 Jun 17</year><fpage>1696</fpage><lpage>1698</lpage><pub-id pub-id-type="doi">10.1021/acschemneuro.0c00239</pub-id><comment>Epub 2020 May 26. PMID: 32452670</comment><pub-id pub-id-type="pmid">32452670</pub-id></element-citation></ref><ref id="bib25"><label>25</label><element-citation publication-type="journal" id="sref25"><person-group person-group-type="author"><name><surname>Dhama</surname><given-names>K.</given-names></name><name><surname>Karthik</surname><given-names>K.</given-names></name><name><surname>Khandia</surname><given-names>R.</given-names></name><name><surname>Munjal</surname><given-names>A.</given-names></name><name><surname>Tiwari</surname><given-names>R.</given-names></name><name><surname>Rana</surname><given-names>R.</given-names></name></person-group><article-title>Medicinal and therapeutic potential of herbs and plant metabolites/extracts countering viral pathogens-current knowledge and future prospects</article-title><source>Curr Drug Metabol</source><volume>19</volume><year>2018</year><fpage>236</fpage><lpage>263</lpage><comment>Available from:</comment><ext-link ext-link-type="uri" xlink:href="https://www.researchgate.net/publication/322793363" id="intref0025">https://www.researchgate.net/publication/322793363</ext-link></element-citation></ref><ref id="bib26"><label>26</label><element-citation publication-type="journal" id="sref26"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Z.</given-names></name><name><surname>Shi</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Huang</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name></person-group><article-title>Pathological findings of COVID-19 associated with acute respiratory distress syndrome</article-title><source>Lancet Respir Med</source><volume>8</volume><year>2020</year><fpage>420</fpage><lpage>422</lpage><pub-id pub-id-type="doi">10.1016/S2213-2600(20)30076-X</pub-id><pub-id pub-id-type="pmid">32085846</pub-id></element-citation></ref><ref id="bib27"><label>27</label><element-citation publication-type="journal" id="sref27"><person-group person-group-type="author"><name><surname>Bhat</surname><given-names>J.</given-names></name><name><surname>Damle</surname><given-names>A.</given-names></name><name><surname>Vaishnav</surname><given-names>P.P.</given-names></name><name><surname>Albers</surname><given-names>R.</given-names></name><name><surname>Joshi</surname><given-names>M.</given-names></name><name><surname>Banerjee</surname><given-names>G.</given-names></name></person-group><article-title>In&#x000a0;vivo enhancement of natural killer cell activity through tea fortified with Ayurvedic herbs</article-title><source>Phytother Res</source><volume>24</volume><year>2010</year><fpage>129</fpage><lpage>135</lpage><pub-id pub-id-type="doi">10.1002/ptr.2889</pub-id><pub-id pub-id-type="pmid">19504465</pub-id></element-citation></ref><ref id="bib28"><label>28</label><element-citation publication-type="journal" id="sref28"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>D.</given-names></name><name><surname>Arya</surname><given-names>V.</given-names></name><name><surname>Kaur</surname><given-names>R.</given-names></name><name><surname>Bhat</surname><given-names>Z.A.</given-names></name><name><surname>Gupta</surname><given-names>V.K.</given-names></name><name><surname>Kumar</surname><given-names>V.</given-names></name></person-group><article-title>A&#x000a0;review of immunomodulators in the Indian traditional health care system</article-title><source>J&#x000a0;Microbiol Immunol Inf</source><volume>45</volume><year>2012</year><fpage>165</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1016/j.jmii.2011.09.030</pub-id></element-citation></ref><ref id="bib29"><label>29</label><element-citation publication-type="other" id="sref29"><ext-link ext-link-type="uri" xlink:href="http://www.ccras.nic.in/sites/default/files/Notices/25042020_Letter_to_States_UTs_for_Ayush_Kwath.pdf" id="intref0030">http://www.ccras.nic.in/sites/default/files/Notices/25042020_Letter_to_States_UTs_for_Ayush_Kwath.pdf</ext-link></element-citation></ref><ref id="bib30"><label>30</label><mixed-citation publication-type="other" id="sref30">Sharma PV. Dravyaguna Vijnana. Vol. II, reprint 2009. Varanasi: Chaukhambha Bharati Academy. pp. 513 and 709, 250, 331 and 362.</mixed-citation></ref><ref id="bib31"><label>31</label><element-citation publication-type="book" id="sref31"><person-group person-group-type="author"><collab>World Health Organization, Regional Office for South-East Asia</collab></person-group><chapter-title>Self-care in the context of primary health care</chapter-title><year>2009</year><publisher-name>WHO Regional Office for South-East Asia</publisher-name><comment>Available from:</comment><ext-link ext-link-type="uri" xlink:href="https://apps.who.int/iris/handle/10665/206352" id="intref0035">https://apps.who.int/iris/handle/10665/206352</ext-link></element-citation></ref><ref id="bib32"><label>32</label><element-citation publication-type="journal" id="sref32"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>M.M.</given-names></name></person-group><article-title>Tulsi &#x02013; <italic>Ocimum sanctum</italic>: a herb for all reasons</article-title><source>J&#x000a0;Ayurveda Integr Med</source><volume>5</volume><year>2014</year><fpage>251</fpage><lpage>259</lpage><pub-id pub-id-type="doi">10.4103/0975-9476.146554</pub-id><pub-id pub-id-type="pmid">25624701</pub-id></element-citation></ref><ref id="bib33"><label>33</label><element-citation publication-type="journal" id="sref33"><person-group person-group-type="author"><name><surname>Suanarunsawat</surname><given-names>T.</given-names></name><name><surname>Ayutthaya</surname><given-names>W.D.N.</given-names></name><name><surname>Songsak</surname><given-names>T.</given-names></name><name><surname>Thirawarapan</surname><given-names>S.</given-names></name><name><surname>Poungshompoo</surname><given-names>S.</given-names></name></person-group><article-title>Lipid-lowering and antioxidative activities of aqueous extracts of <italic>Ocimum sanctum</italic> L. leaves in rats fed with a high-cholesterol diet</article-title><source>Oxid Med Cell Longev</source><volume>2011</volume><year>2011</year><fpage>962025</fpage><pub-id pub-id-type="doi">10.1155/2011/962025</pub-id><pub-id pub-id-type="pmid">21949899</pub-id></element-citation></ref><ref id="bib34"><label>34</label><element-citation publication-type="journal" id="sref34"><person-group person-group-type="author"><name><surname>Mohan</surname><given-names>L.</given-names></name><name><surname>Amberkar</surname><given-names>M.V.</given-names></name><name><surname>Kumari</surname><given-names>M.</given-names></name></person-group><article-title><italic>Ocimum sanctum</italic> Linn. (TULSI) &#x02013; an overview</article-title><source>Int J Pharmaceut Sci Rev Res</source><volume>7</volume><year>2011</year><fpage>51</fpage><lpage>53</lpage><comment>Available from:</comment><ext-link ext-link-type="uri" xlink:href="http://twcleansecommunity.com/wp-content/uploads/2014/03/Tulsi-Research-Mohan-Ocimum-sanctum-an-overview.pdf" id="intref0040">http://twcleansecommunity.com/wp-content/uploads/2014/03/Tulsi-Research-Mohan-Ocimum-sanctum-an-overview.pdf</ext-link></element-citation></ref><ref id="bib35"><label>35</label><element-citation publication-type="journal" id="sref35"><person-group person-group-type="author"><name><surname>Pattanayak</surname><given-names>P.</given-names></name><name><surname>Behera</surname><given-names>P.</given-names></name><name><surname>Das</surname><given-names>D.</given-names></name><name><surname>Panda</surname><given-names>S.</given-names></name></person-group><article-title><italic>Ocimum sanctum</italic> Linn. A reservoir plant for therapeutic applications: an overview</article-title><source>Phcog Rev</source><volume>4</volume><year>2010</year><fpage>95</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.4103/0973-7847.65323</pub-id><pub-id pub-id-type="pmid">22228948</pub-id></element-citation></ref><ref id="bib36"><label>36</label><element-citation publication-type="journal" id="sref36"><person-group person-group-type="author"><name><surname>Vasudevan</surname><given-names>P.</given-names></name><name><surname>Kashyap</surname><given-names>S.</given-names></name><name><surname>Sharma</surname><given-names>S.</given-names></name></person-group><article-title>Bioactive botanicals from basil (<italic>Ocimum</italic> sp.)</article-title><source>J&#x000a0;Sci Ind Res</source><volume>58</volume><year>1999</year><fpage>332</fpage><lpage>338</lpage><comment>Available from:</comment><ext-link ext-link-type="uri" xlink:href="http://nopr.niscair.res.in/handle/123456789/17820" id="intref0045">http://nopr.niscair.res.in/handle/123456789/17820</ext-link></element-citation></ref><ref id="bib37"><label>37</label><element-citation publication-type="journal" id="sref37"><person-group person-group-type="author"><name><surname>Panda</surname><given-names>V.S.</given-names></name><name><surname>Suresh</surname><given-names>R.N.</given-names></name></person-group><article-title>Evaluation of cardioprotective activity of <italic>Ginkgo biloba</italic> and <italic>Ocimum sanctum</italic> in rodents</article-title><source>Altern Med Rev</source><volume>14</volume><year>2009</year><fpage>161</fpage><lpage>171</lpage><comment>Available from:</comment><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/19594225" id="intref0050">https://www.ncbi.nlm.nih.gov/pubmed/19594225</ext-link><pub-id pub-id-type="pmid">19594225</pub-id></element-citation></ref><ref id="bib38"><label>38</label><element-citation publication-type="journal" id="sref38"><person-group person-group-type="author"><name><surname>Lo</surname><given-names>A.-H.</given-names></name><name><surname>Liang</surname><given-names>Y.-C.</given-names></name><name><surname>Lin-Shiau</surname><given-names>S.-Y.</given-names></name><name><surname>Ho</surname><given-names>C.-T.</given-names></name><name><surname>Lin</surname><given-names>J.-K.</given-names></name></person-group><article-title>Carnosol, an antioxidant in rosemary, suppresses inducible nitric oxide synthase through down-regulating nuclear factor-kappaB in mouse macrophages</article-title><source>Carcinogenesis</source><volume>23</volume><year>2002</year><fpage>983</fpage><lpage>991</lpage><pub-id pub-id-type="doi">10.1093/carcin/23.6.983</pub-id><pub-id pub-id-type="pmid">12082020</pub-id></element-citation></ref><ref id="bib39"><label>39</label><element-citation publication-type="book" id="sref39"><person-group person-group-type="author"><name><surname>Mondal</surname><given-names>S.</given-names></name></person-group><chapter-title>Antimicrobial and immunomodulatory effects of Tulsi (<italic>Oscimum snctum</italic> Linn.)</chapter-title><year>2010</year><comment>Available from:</comment><ext-link ext-link-type="uri" xlink:href="http://ayushportal.nic.in/EMR/CLINICAL_FINAL_REPORT-4.pdf" id="intref0055">http://ayushportal.nic.in/EMR/CLINICAL_FINAL_REPORT-4.pdf</ext-link></element-citation></ref><ref id="bib40"><label>40</label><element-citation publication-type="journal" id="sref40"><person-group person-group-type="author"><name><surname>Hemalatha</surname><given-names>R.</given-names></name><name><surname>Babu</surname><given-names>K.N.</given-names></name><name><surname>Karthik</surname><given-names>M.</given-names></name><name><surname>Ramesh</surname><given-names>R.</given-names></name><name><surname>Kumar</surname><given-names>B.D.</given-names></name><name><surname>Kumar</surname><given-names>P.U.</given-names></name></person-group><article-title>Immunomodulatory activity and Th1/Th2 cytokine response of <italic>Ocimum sanctum</italic> in myelosuppressed swiss albino mice</article-title><source>Trends Med Res</source><volume>6</volume><year>2011</year><fpage>23</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.3923/tmr.2011.23.31</pub-id><ext-link ext-link-type="uri" xlink:href="https://scialert.net/abstract/?doi=tmr.2011.23.31" id="intref0060">https://scialert.net/abstract/?doi=tmr.2011.23.31</ext-link></element-citation></ref><ref id="bib41"><label>41</label><element-citation publication-type="journal" id="sref41"><person-group person-group-type="author"><name><surname>Jamshidi</surname><given-names>N.</given-names></name><name><surname>Cohen</surname><given-names>M.M.</given-names></name></person-group><article-title>The clinical efficacy and safety of Tulsi in humans: a systematic review of the literature</article-title><source>Evid Compl Altern Med</source><volume>2017</volume><year>2017</year><fpage>9217567</fpage><pub-id pub-id-type="doi">10.1155/2017/9217567</pub-id></element-citation></ref><ref id="bib42"><label>42</label><element-citation publication-type="journal" id="sref42"><person-group person-group-type="author"><name><surname>Gautam</surname><given-names>M.K.</given-names></name><name><surname>Goel</surname><given-names>R.K.</given-names></name></person-group><article-title>Toxicological study of <italic>Ocimum sanctum</italic> Linn leaves: hematological, biochemical, and histopathological studies</article-title><source>J&#x000a0;Toxicol</source><volume>2014</volume><year>2014</year><fpage>135654</fpage><pub-id pub-id-type="doi">10.1155/2014/135654</pub-id><comment>Epub 2014 Jan 29. PMID: 24616736; PMCID: PMC3927567</comment><pub-id pub-id-type="pmid">24616736</pub-id></element-citation></ref><ref id="bib43"><label>43</label><element-citation publication-type="other" id="sref43"><ext-link ext-link-type="uri" xlink:href="http://ccras.nic.in/content/important-uses-dalchini" id="intref0065">http://ccras.nic.in/content/important-uses-dalchini</ext-link></element-citation></ref><ref id="bib44"><label>44</label><element-citation publication-type="journal" id="sref44"><person-group person-group-type="author"><name><surname>Niphade</surname><given-names>S.R.</given-names></name><name><surname>Asad</surname><given-names>M.</given-names></name><name><surname>Chandrakala</surname><given-names>G.K.</given-names></name><name><surname>Toppo</surname><given-names>E.</given-names></name><name><surname>Deshmukh</surname><given-names>P.</given-names></name></person-group><article-title>Immunomodulatory activity of <italic>Cinnamomum zeylanicum</italic> Bark</article-title><source>Pharmaceut Biol</source><volume>47</volume><year>2009</year><fpage>1168</fpage><lpage>1173</lpage><pub-id pub-id-type="doi">10.3109/13880200903019234</pub-id></element-citation></ref><ref id="bib45"><label>45</label><element-citation publication-type="journal" id="sref45"><person-group person-group-type="author"><name><surname>Valizadeh</surname><given-names>S.</given-names></name><name><surname>Katiraee</surname><given-names>F.</given-names></name><name><surname>Mahmoudi</surname><given-names>R.</given-names></name><name><surname>Fakheri</surname><given-names>T.</given-names></name><name><surname>Mardani</surname><given-names>K.</given-names></name></person-group><article-title>Biological properties of <italic>Cinnamomum zeylanicum</italic> essential oil: phytochemical component, antioxidant and antimicrobial activities</article-title><source>Int J Food Nutr Saf</source><volume>6</volume><year>2015</year><fpage>174</fpage><lpage>184</lpage><comment>Available from:</comment><ext-link ext-link-type="uri" xlink:href="https://www.researchgate.net/publication/341077278" id="intref0070">https://www.researchgate.net/publication/341077278</ext-link></element-citation></ref><ref id="bib46"><label>46</label><element-citation publication-type="journal" id="sref46"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>B.H.</given-names></name><name><surname>Lee</surname><given-names>Y.G.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>Lee</surname><given-names>J.Y.</given-names></name><name><surname>Cho</surname><given-names>J.Y.</given-names></name></person-group><article-title>Regulatory effect of cinnamaldehyde on monocyte/macrophage-mediated inflammatory responses</article-title><source>Mediat Inflamm</source><volume>2010</volume><year>2010</year><fpage>529359</fpage><pub-id pub-id-type="doi">10.1155/2010/529359</pub-id></element-citation></ref><ref id="bib47"><label>47</label><element-citation publication-type="journal" id="sref47"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>B.-J.</given-names></name><name><surname>Kim</surname><given-names>Y.-J.</given-names></name><name><surname>Cho</surname><given-names>D.-H.</given-names></name><name><surname>Sohn</surname><given-names>N.-W.</given-names></name><name><surname>Kang</surname><given-names>H.</given-names></name></person-group><article-title>Immunomodulatory effect of water extract of cinnamon on anti-CD3-induced cytokine responses and p38, JNK, ERK1/2, and STAT4 activation</article-title><source>Immunopharmacol Immunotoxicol</source><volume>33</volume><year>2011</year><fpage>714</fpage><lpage>722</lpage><pub-id pub-id-type="doi">10.3109/08923973.2011.564185</pub-id><pub-id pub-id-type="pmid">22053946</pub-id></element-citation></ref><ref id="bib48"><label>48</label><element-citation publication-type="journal" id="sref48"><person-group person-group-type="author"><name><surname>Tsui</surname><given-names>P.-F.</given-names></name><name><surname>Lin</surname><given-names>C.-S.</given-names></name><name><surname>Ho</surname><given-names>L.-J.</given-names></name><name><surname>Lai</surname><given-names>J.-H.</given-names></name></person-group><article-title>Spices and atherosclerosis</article-title><source>Nutrients</source><volume>10</volume><year>2018</year><pub-id pub-id-type="doi">10.3390/nu10111724</pub-id></element-citation></ref><ref id="bib49"><label>49</label><element-citation publication-type="journal" id="sref49"><person-group person-group-type="author"><name><surname>Hajimonfarednejad</surname><given-names>M.</given-names></name><name><surname>Ostovar</surname><given-names>M.</given-names></name><name><surname>Raee</surname><given-names>M.J.</given-names></name><name><surname>Hashempur</surname><given-names>M.H.</given-names></name><name><surname>Mayer</surname><given-names>J.G.</given-names></name><name><surname>Heydari</surname><given-names>M.</given-names></name></person-group><article-title>Cinnamon: a systematic review of adverse events</article-title><source>Clin Nutr</source><volume>38</volume><issue>2</issue><year>2019 Apr</year><fpage>594</fpage><lpage>602</lpage><pub-id pub-id-type="doi">10.1016/j.clnu.2018.03.013</pub-id><comment>Epub 2018 Apr 5. PMID: 29661513. Available from:</comment><ext-link ext-link-type="uri" xlink:href="http://eprints.fums.ac.ir/2609/1/Cinnamon%20A%20systematic%20review%20of%20adverse%20events.pdf" id="intref0075">http://eprints.fums.ac.ir/2609/1/Cinnamon%20A%20systematic%20review%20of%20adverse%20events.pdf</ext-link><pub-id pub-id-type="pmid">29661513</pub-id></element-citation></ref><ref id="bib50"><label>50</label><element-citation publication-type="book" id="sref50"><person-group person-group-type="author"><name><surname>Bode</surname><given-names>A.M.</given-names></name><name><surname>Dong</surname><given-names>Z.</given-names></name></person-group><chapter-title>The amazing and mighty ginger</chapter-title><person-group person-group-type="editor"><name><surname>Benzie</surname><given-names>I.F.F.</given-names></name><name><surname>Wachtel-Galor</surname><given-names>S.</given-names></name></person-group><source>Herbal medicine: biomolecular and clinical aspects</source><edition>2nd ed.</edition><year>2011</year><publisher-name>CRC Press/Taylor &#x00026; Francis</publisher-name><publisher-loc>Boca Raton (FL)</publisher-loc><comment>[Chapter 7]. Available from:</comment><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK92775/" id="intref0080">https://www.ncbi.nlm.nih.gov/books/NBK92775/</ext-link></element-citation></ref><ref id="bib51"><label>51</label><element-citation publication-type="journal" id="sref51"><person-group person-group-type="author"><name><surname>Dhea Kharisma</surname><given-names>V.</given-names></name><name><surname>Septiadi</surname><given-names>L.</given-names></name></person-group><article-title>Prediction of novel bioactive compound from <italic>Z.&#x000a0;officinale</italic> as non-nucleoside reverse transcriptase inhibitors (NNRTIs) of HIV-1 through computational study</article-title><source>Bioinf Biomed Res J</source><volume>1</volume><year>2018</year><fpage>49</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.11594/bbrj.01.02.05</pub-id></element-citation></ref><ref id="bib52"><label>52</label><element-citation publication-type="book" id="sref52"><person-group person-group-type="author"><name><surname>Chopra</surname><given-names>R.N.</given-names></name><name><surname>Chopra</surname><given-names>I.C.</given-names></name><name><surname>Ishwar</surname><given-names>C.</given-names></name><name><surname>Nayer</surname><given-names>S.L.</given-names></name></person-group><chapter-title>Glossary of Indian medicinal plants</chapter-title><year>1956</year><publisher-name>Council of Scientific and Industrial Research</publisher-name><publisher-loc>New Delhi</publisher-loc><comment>Available from:</comment><ext-link ext-link-type="uri" xlink:href="https://www.researchgate.net/publication/340809680_AIJR_Preprints_Reconsidering_Traditional_Medicinal_Plants_to_Combat_COVID-19" id="intref0085">https://www.researchgate.net/publication/340809680_AIJR_Preprints_Reconsidering_Traditional_Medicinal_Plants_to_Combat_COVID-19</ext-link></element-citation></ref><ref id="bib53"><label>53</label><element-citation publication-type="journal" id="sref53"><person-group person-group-type="author"><name><surname>Habib</surname><given-names>S.H.M.</given-names></name><name><surname>Makpol</surname><given-names>S.</given-names></name><name><surname>Abdul Hamid</surname><given-names>N.A.</given-names></name><name><surname>Das</surname><given-names>S.</given-names></name><name><surname>Ngah</surname><given-names>W.Z.W.</given-names></name><name><surname>Yusof</surname><given-names>Y.A.M.</given-names></name></person-group><article-title>Ginger extract (<italic>Zingiber officinale</italic>) has anti-cancer and anti-inflammatory effects on ethionine-induced hepatoma rats</article-title><source>Clinics</source><volume>63</volume><year>2008</year><fpage>807</fpage><lpage>813</lpage><pub-id pub-id-type="doi">10.1590/s1807-59322008000600017</pub-id><pub-id pub-id-type="pmid">19061005</pub-id></element-citation></ref><ref id="bib54"><label>54</label><element-citation publication-type="journal" id="sref54"><person-group person-group-type="author"><name><surname>Verma</surname><given-names>S.K.</given-names></name><name><surname>Singh</surname><given-names>M.</given-names></name><name><surname>Jain</surname><given-names>P.</given-names></name><name><surname>Bordia</surname><given-names>A.</given-names></name></person-group><article-title>Protective effect of ginger, <italic>Zingiber officinale</italic> Rosc on experimental atherosclerosis in rabbits</article-title><source>Indian J Exp Biol</source><volume>42</volume><year>2004</year><fpage>736</fpage><lpage>738</lpage><comment>Available from:</comment><ext-link ext-link-type="uri" xlink:href="http://nopr.niscair.res.in/bitstream/123456789/23544/1/IJEB%2042(7)%20736-738.pdf" id="intref0090">http://nopr.niscair.res.in/bitstream/123456789/23544/1/IJEB%2042(7)%20736-738.pdf</ext-link><pub-id pub-id-type="pmid">15339040</pub-id></element-citation></ref><ref id="bib55"><label>55</label><element-citation publication-type="journal" id="sref55"><person-group person-group-type="author"><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name><name><surname>Shishodia</surname><given-names>S.</given-names></name></person-group><article-title>Molecular targets of dietary agents for prevention and therapy of cancer</article-title><source>Biochem Pharmacol</source><volume>71</volume><year>2006</year><fpage>1397</fpage><lpage>1421</lpage><pub-id pub-id-type="doi">10.1016/j.bcp.2006.02.009</pub-id><pub-id pub-id-type="pmid">16563357</pub-id></element-citation></ref><ref id="bib56"><label>56</label><element-citation publication-type="journal" id="sref56"><person-group person-group-type="author"><name><surname>Mashhadi</surname><given-names>N.S.</given-names></name><name><surname>Ghiasvand</surname><given-names>R.</given-names></name><name><surname>Askari</surname><given-names>G.</given-names></name><name><surname>Hariri</surname><given-names>M.</given-names></name><name><surname>Darvishi</surname><given-names>L.</given-names></name><name><surname>Mofid</surname><given-names>M.R.</given-names></name></person-group><article-title>Anti-oxidative and anti-inflammatory effects of ginger in health and physical activity: review of current evidence</article-title><source>Int J Prev Med</source><volume>4</volume><year>2013</year><fpage>S36</fpage><lpage>S42</lpage><pub-id pub-id-type="pmid">23717767</pub-id></element-citation></ref><ref id="bib57"><label>57</label><element-citation publication-type="journal" id="sref57"><person-group person-group-type="author"><name><surname>Mahluji</surname><given-names>S.</given-names></name><name><surname>Ostadrahimi</surname><given-names>A.</given-names></name><name><surname>Mobasseri</surname><given-names>M.</given-names></name><name><surname>Ebrahimzade Attari</surname><given-names>V.</given-names></name><name><surname>Payahoo</surname><given-names>L.</given-names></name></person-group><article-title>Anti-inflammatory effects of <italic>Zingiber officinale</italic> in type 2 diabetic patients</article-title><source>Adv Pharmaceut Bull</source><volume>3</volume><year>2013</year><fpage>273</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.5681/apb.2013.044</pub-id></element-citation></ref><ref id="bib58"><label>58</label><element-citation publication-type="journal" id="sref58"><person-group person-group-type="author"><name><surname>Zehsaz</surname><given-names>F.</given-names></name><name><surname>Farhangi</surname><given-names>N.</given-names></name><name><surname>Mirheidari</surname><given-names>L.</given-names></name></person-group><article-title>The effect of <italic>Zingiber officinale</italic> R. rhizomes (ginger) on plasma pro-inflammatory cytokine levels in well-trained male endurance runners</article-title><source>Centr Eur J Immunol</source><volume>39</volume><year>2014</year><fpage>174</fpage><lpage>180</lpage><pub-id pub-id-type="doi">10.5114/ceji.2014.43719</pub-id></element-citation></ref><ref id="bib59"><label>59</label><element-citation publication-type="journal" id="sref59"><person-group person-group-type="author"><name><surname>Mahassni</surname><given-names>S.H.</given-names></name><name><surname>Bukhari</surname><given-names>O.A.</given-names></name></person-group><article-title>Beneficial effects of an aqueous ginger extract on the immune system cells and antibodies, hematology, and thyroid hormones in male smokers and non-smokers</article-title><source>J&#x000a0;Nutr Intermed Metab</source><volume>15</volume><year>2019</year><fpage>10</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1016/j.jnim.2018.10.001</pub-id></element-citation></ref><ref id="bib60"><label>60</label><element-citation publication-type="journal" id="sref60"><person-group person-group-type="author"><name><surname>Stanisiere</surname><given-names>J.</given-names></name><name><surname>Mousset</surname><given-names>P.Y.</given-names></name><name><surname>Lafay</surname><given-names>S.</given-names></name></person-group><article-title>How safe is ginger rhizome for decreasing nausea and vomiting in women during early pregnancy?</article-title><source>Foods</source><volume>7</volume><issue>4</issue><year>2018 Apr 1</year><fpage>50</fpage><pub-id pub-id-type="doi">10.3390/foods7040050</pub-id><comment>PMID: 29614764; PMCID: PMC5920415</comment></element-citation></ref><ref id="bib61"><label>61</label><element-citation publication-type="journal" id="sref61"><person-group person-group-type="author"><name><surname>Viljoen</surname><given-names>E.</given-names></name><name><surname>Visser</surname><given-names>J.</given-names></name><name><surname>Koen</surname><given-names>N.</given-names></name><name><surname>Musekiwa</surname><given-names>A.</given-names></name></person-group><article-title>A&#x000a0;systematic review and meta-analysis of the effect and safety of ginger in the treatment of pregnancy-associated nausea and vomiting</article-title><source>Nutr J</source><volume>13</volume><year>2014 Mar 19</year><fpage>20</fpage><pub-id pub-id-type="doi">10.1186/1475-2891-13-20</pub-id><comment>PMID: 24642205; PMCID: PMC3995184</comment><pub-id pub-id-type="pmid">24642205</pub-id></element-citation></ref><ref id="bib62"><label>62</label><element-citation publication-type="journal" id="sref62"><person-group person-group-type="author"><name><surname>Peterson</surname><given-names>C.T.</given-names></name><name><surname>Rodionov</surname><given-names>D.A.</given-names></name><name><surname>Iablokov</surname><given-names>S.N.</given-names></name><name><surname>Pung</surname><given-names>M.A.</given-names></name><name><surname>Chopra</surname><given-names>D.</given-names></name><name><surname>Mills</surname><given-names>P.J.</given-names></name></person-group><article-title>Prebiotic potential of culinary spices used to support digestion and bioabsorption</article-title><source>Evid Compl Alternative Med: ECAM</source><volume>2019</volume><year>2019</year><fpage>8973704</fpage><pub-id pub-id-type="doi">10.1155/2019/8973704</pub-id></element-citation></ref><ref id="bib63"><label>63</label><element-citation publication-type="journal" id="sref63"><person-group person-group-type="author"><name><surname>Damanhouri</surname><given-names>Z.A.</given-names></name></person-group><article-title>A&#x000a0;review on therapeutic potential of <italic>Piper nigrum</italic> L. (Black Pepper): the king of spices</article-title><source>Med Aromat Plants</source><volume>3</volume><year>2014</year><pub-id pub-id-type="doi">10.4172/2167-0412.1000161</pub-id></element-citation></ref><ref id="bib64"><label>64</label><element-citation publication-type="journal" id="sref64"><person-group person-group-type="author"><name><surname>Nahak</surname><given-names>G.</given-names></name><name><surname>Sahu</surname><given-names>R.K.</given-names></name></person-group><article-title>Phytochemical evaluation and antioxidant activity of <italic>Piper cubeba</italic> and <italic>Piper nigrum</italic></article-title><source>J&#x000a0;Appl Pharmaceut Sci</source><volume>1</volume><year>2011</year><fpage>153</fpage><lpage>157</lpage><comment>Available from:</comment><ext-link ext-link-type="uri" xlink:href="https://japsonline.com/admin/php/uploads/231_pdf.pdf" id="intref0095">https://japsonline.com/admin/php/uploads/231_pdf.pdf</ext-link></element-citation></ref><ref id="bib65"><label>65</label><element-citation publication-type="journal" id="sref65"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>A.K.</given-names></name><name><surname>Singh</surname><given-names>V.K.</given-names></name></person-group><article-title>Biological action of <italic>Piper nigrum</italic> &#x02013; the king of spices</article-title><source>Eur J Biol Res</source><year>2017</year><pub-id pub-id-type="doi">10.5281/zenodo.839039</pub-id></element-citation></ref><ref id="bib66"><label>66</label><element-citation publication-type="journal" id="sref66"><person-group person-group-type="author"><name><surname>Balkrishna</surname><given-names>A.</given-names></name><name><surname>Solleti</surname><given-names>S.K.</given-names></name><name><surname>Singh</surname><given-names>H.</given-names></name><name><surname>Tomer</surname><given-names>M.</given-names></name><name><surname>Sharma</surname><given-names>N.</given-names></name><name><surname>Varshney</surname><given-names>A.</given-names></name></person-group><article-title>Calcio-herbal formulation, Divya-Swasari-Ras, alleviates chronic inflammation and suppresses airway remodelling in mouse model of allergic asthma by modulating pro-inflammatory cytokine response</article-title><source>Biomed Pharmacother</source><volume>126</volume><year>2020</year><pub-id pub-id-type="doi">10.1016/j.biopha.2020.110063</pub-id></element-citation></ref><ref id="bib67"><label>67</label><element-citation publication-type="journal" id="sref67"><person-group person-group-type="author"><name><surname>Bui</surname><given-names>T.T.</given-names></name><name><surname>Piao</surname><given-names>C.H.</given-names></name><name><surname>Hyeon</surname><given-names>E.</given-names></name><name><surname>Fan</surname><given-names>Y.</given-names></name><name><surname>Van Nguyen</surname><given-names>T.</given-names></name><name><surname>Jung</surname><given-names>S.Y.</given-names></name></person-group><article-title>The protective role of <italic>Piper nigrum</italic> fruit extract in an ovalbumin-induced allergic rhinitis by targeting of NF&#x003ba;Bp65 and STAT3 signalings</article-title><source>Biomed Pharmacother</source><volume>109</volume><year>2019</year><fpage>1915</fpage><lpage>1923</lpage><pub-id pub-id-type="doi">10.1016/J.BIOPHA.2018.11.073</pub-id><pub-id pub-id-type="pmid">30551446</pub-id></element-citation></ref><ref id="bib68"><label>68</label><element-citation publication-type="journal" id="sref68"><person-group person-group-type="author"><name><surname>Zhai</surname><given-names>W.-J.</given-names></name><name><surname>Zhang</surname><given-names>Z.-B.</given-names></name><name><surname>Xu</surname><given-names>N.-N.</given-names></name><name><surname>Guo</surname><given-names>Y.-F.</given-names></name><name><surname>Qiu</surname><given-names>C.</given-names></name><name><surname>Li</surname><given-names>C.-Y.</given-names></name></person-group><article-title>Piperine plays an anti-inflammatory role in <italic>Staphylococcus aureus</italic> endometritis by inhibiting activation of NF-&#x003ba;B and MAPK pathways in mice</article-title><source>Evid Compl Altern Med</source><volume>2016</volume><year>2016</year><fpage>8597208</fpage><pub-id pub-id-type="doi">10.1155/2016/8597208</pub-id></element-citation></ref><ref id="bib69"><label>69</label><element-citation publication-type="journal" id="sref69"><person-group person-group-type="author"><name><surname>Paarakh</surname><given-names>P.M.</given-names></name><name><surname>Sreeram</surname><given-names>D.C.</given-names></name><name><surname>D SS</surname></name><name><surname>Ganapathy</surname><given-names>S.P.S.</given-names></name></person-group><article-title>In&#x000a0;vitro cytotoxic and in silico activity of piperine isolated from <italic>Piper nigrum</italic> fruits Linn</article-title><source>Silico Pharmacol</source><volume>3</volume><year>2015</year><fpage>9</fpage><pub-id pub-id-type="doi">10.1186/s40203-015-0013-2</pub-id></element-citation></ref><ref id="bib70"><label>70</label><element-citation publication-type="journal" id="sref70"><person-group person-group-type="author"><name><surname>Subehan</surname><given-names>Usia T.</given-names></name><name><surname>Kadota</surname><given-names>S.</given-names></name><name><surname>Tezuka</surname><given-names>Y.</given-names></name></person-group><article-title>Alkamides from <italic>Piper nigrum</italic> L. and their inhibitory activity against human liver microsomal cytochrome P450 2D6 (CYP2D6)</article-title><source>Nat Prod Commun</source><volume>1</volume><year>2006</year><pub-id pub-id-type="doi">10.1177/1934578X0600100101</pub-id></element-citation></ref><ref id="bib71"><label>71</label><element-citation publication-type="journal" id="sref71"><person-group person-group-type="author"><name><surname>Rajkumar</surname><given-names>R.P.</given-names></name></person-group><article-title>Ayurveda and COVID-19: where psychoneuroimmunology and the meaning response meet</article-title><source>Brain Behav Immun</source><volume>87</volume><year>2020 Jul</year><fpage>8</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.bbi.2020.04.056</pub-id><comment>Epub 2020 Apr 22. PMID: 32334064; PMCID: PMC7175849</comment><pub-id pub-id-type="pmid">32334064</pub-id></element-citation></ref><ref id="bib72"><label>72</label><element-citation publication-type="journal" id="sref72"><person-group person-group-type="author"><name><surname>Mehta</surname><given-names>P.</given-names></name><name><surname>McAuley</surname><given-names>D.F.</given-names></name><name><surname>Brown</surname><given-names>M.</given-names></name><name><surname>Sanchez</surname><given-names>E.</given-names></name><name><surname>Tattersall</surname><given-names>R.S.</given-names></name><name><surname>Manson</surname><given-names>J.J.</given-names></name></person-group><article-title>COVID-19: consider cytokine storm syndromes and immunosuppression</article-title><source>Lancet</source><volume>395</volume><year>2020</year><fpage>1033</fpage><lpage>1034</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(20)30628-0</pub-id><pub-id pub-id-type="pmid">32192578</pub-id></element-citation></ref><ref id="bib73"><label>73</label><element-citation publication-type="book" id="sref73"><person-group person-group-type="editor"><name><surname>Benzie</surname><given-names>I.F.F.</given-names></name><name><surname>Wachtel-Galor</surname><given-names>S.</given-names></name></person-group><source>Herbal medicine: biomolecular and clinical aspects</source><edition>2nd ed.</edition><year>2011</year><publisher-name>CRC Press/Taylor &#x00026; Francis</publisher-name><publisher-loc>Boca Raton (FL)</publisher-loc><comment>Available from:</comment><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK92771/" id="intref0100">https://www.ncbi.nlm.nih.gov/books/NBK92771/</ext-link></element-citation></ref><ref id="bib74"><label>74</label><element-citation publication-type="journal" id="sref74"><person-group person-group-type="author"><name><surname>Karole</surname><given-names>S.</given-names></name><name><surname>Shrivastava</surname><given-names>S.</given-names></name><name><surname>Thomas</surname><given-names>S.</given-names></name><name><surname>Soni</surname><given-names>B.</given-names></name><name><surname>Khan</surname><given-names>S.</given-names></name><name><surname>Dubey</surname><given-names>J.</given-names></name></person-group><article-title>Polyherbal formulation concept for synergic action: a review</article-title><source>JDDT [Internet]</source><volume>9</volume><issue>1-s</issue><year>2019</year><fpage>453</fpage><lpage>466</lpage><comment>Available from:</comment><ext-link ext-link-type="uri" xlink:href="http://jddtonline.info/index.php/jddt/article/view/2339" id="intref0105">http://jddtonline.info/index.php/jddt/article/view/2339</ext-link></element-citation></ref><ref id="bib75"><label>75</label><mixed-citation publication-type="other" id="sref75">Anonymous. The ayurvedic pharmacopoeia of India part-I and volume-I, II and III. Ministry of Health and Family Welfare, Govt. of India, New Delhi.</mixed-citation></ref><ref id="bib76"><label>76</label><element-citation publication-type="book" id="sref76"><person-group person-group-type="author"><name><surname>Pole</surname><given-names>Sebastian</given-names></name><name><surname>Lic</surname><given-names>O.H.M.</given-names></name><name><surname>Ayur</surname><given-names>H.C.</given-names></name></person-group><chapter-title>Ayurvedic medicine: the principles of traditional practice</chapter-title><year>2006</year><publisher-name>Elsevier</publisher-name><fpage>315</fpage><comment>Available from:</comment><ext-link ext-link-type="uri" xlink:href="https://books.google.co.in/books?id=hBT6yHZckS4C&#x00026;printsec=frontcover#v=onepage&#x00026;q&#x00026;f=false%20Acessed" id="intref0110">https://books.google.co.in/books?id=hBT6yHZckS4C&#x00026;amp;printsec=frontcover#v=onepage&#x00026;amp;q&#x00026;amp;f=false Acessed</ext-link></element-citation></ref><ref id="bib77"><label>77</label><element-citation publication-type="journal" id="sref77"><person-group person-group-type="author"><name><surname>Nayeem</surname><given-names>N.</given-names></name><name><surname>Kavitha</surname><given-names>A.</given-names></name><name><surname>Deepthi</surname><given-names>V.</given-names></name></person-group><article-title>Design, formulation and evaluation of a polyherbal ointment for its wound healing activity</article-title><source>Pharmacophore</source><volume>4</volume><year>2013</year><fpage>175</fpage><lpage>180</lpage></element-citation></ref></ref-list><fn-group><fn id="d33e772"><p id="ntpara0010">Peer review under responsibility of Transdisciplinary University, Bangalore.</p></fn></fn-group></back></article>